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11. INTRODUCTION
A number of studies from Romania, Germany, The Netherlands, France, Japan have
suggested that the prevalence of cholesterol gallstones (GS), especially in affluent
countries, has increased substantially during the twentieth century1 2 3 4, whereas it is
rare in Asia and Africa5 6. These findings indicate that cholelithiasis might be a disease
affected by genetic factors, but environmental factors and lifestyle habits might be just
as or more important.
Cholelithiasis is today, together with Heart disease (HD) and Diabetes Mellitus (DM),
one of the most frequent diseases in industrialized countries and affects about 15% of
Western populations 7. 10 % of the male population and 20% of the female population
suffer from cholelithiasis8. In Germany, it was suggested that around 7-9 million people
suffer from GSs. In Israel, the prevalence of GS amounts to almost 30% of the
population above age 709. Most GS patients suffer from asymptomatic, ‘silent’, GS and
therefore remain unknown. Only about 20% of GS carriers report symptoms, which in
most cases lead to operative removal of the gallbladder (GB) [cholecystectomy], which
up until about 20 years ago was the only therapy for GS 10.
                                                                
1 Acalovschi et al, 1987
2 Balzer et al, 1986
3 Sarles et al, 1978
4 Nakayama et al, 1970
5 Swang WS, 1970
6 Biss et al, 1971
7 Diehl AK, 1991
8 Thijs et al, 1990
9 Gilat et al, 1985
10 Barbara et al, 1987
2Despite the large number of studies in recent decades the etiology and pathogenesis of
GS have not been elucidated. Family and twin studies1 2 3 4 5 6 7 as well as high
prevalence in certain populations, such as Pima-, Chippewa-, MicMac-, Sioux- and
Navajo Indians 8 confirm the effect of genetic factors. The major increases in GS
prevalence within defined populations in a matter of decades indicate the effects of
environmental factors. Genetic and environmental factors may well exist, the changing
environment affecting mostly those who are genetically predisposed. Diet has long been
suspected to be one of these putative environmental factors. Differences in GS
prevalence between populations consuming a low calorie subsistence diet and
populations in affluent countries having a surfeit of food9 10. The rapid formation of GS
in obesity11 12 13 14 15 16 17, rapid weight loss18 19 20, parenteral feeding21, as well as in
people consuming special diets22 all point in that direction.
                                                                
1 Sarin et al, 1995
2 Nurnberg et al, 1989
3 Danziger et al, 1972
4 Gilat et al, 1983
5 Antero Kesaniemi et al, 1989
6 Doig RK, 1957
7 Brown et al, 1968
8 Sampliner et al, 1970
9 Sarles et al, 1969 & 1978
10 Gilat et al, 1985
11 Friedman et al, 1966
12 Kern F Jr, 1983
13 Scragg et al, 1984
14 Diehl et al, 1987
15 Barbara et al, 1987
16 GREPCO, 1988
17 Maclure et al, 1989
18 Liddle et al, 1989
19 Sichieri et al, 1991
20 Yang et al, 1992
21 Akierman et al, 1984
22 Sturdevant et al, 1973
3Danziger et al 1 showed that in some cholesterol GS patients who were fed high doses of
chenodeoxycholic acid (and later its epimer ursodeoxycholic acid), the GS dissolved.
Over the years, it became clear that this kind of treatment is only suitable for around
20% or less of GS carriers2. Therefore cholecystectomy is presently one of the most
common operations and accounts for a high percentage of hospital expenses and health
insurance companies.
1.1 Aims and Hypothesis
There have been quite a large number of studies analyzing diet and GS, however no
definitive conclusions have emerged. On reviewing these studies several flaws in the
research protocols have been identified:
§ inclusion of symptomatic GS carriers (might influence usual eating habits)
§ no ascertainment of GB status of all cases and controls
§ bad choice of study subjects (volunteers, nurses, hospital-based controls), who do
not necessarily represent the entire population for whom the results are supposedly
applicable
§ multiple interviewers (might introduce inter-observer bias)
§ limited questionnaires unable to give a true picture of habitual dietary intake, and
other problems discussed later.
                                                                
1 Danziger et al, 1972
2 Fromm et al, 1986
4The present study evaluated the potential association between GS and diet trying to
avoid some of the shortcomings of previous study protocols. Lifestyle habits were also
analyzed. All study subjects (cases and controls) had US examination of their GB to
ascertain the presence of GS. All GS carriers were asymptomatic, allowing analysis of
diet and lifestyle prior to onset of symptoms.
The matching was complete and included not only gender and age but also community
group (which may heavily influence dietary habits). Two hundred and six subjects were
studied, 103 GS carriers and 103 controls, without GS.
52. SCIENTIFIC BACKGROUND
Below you will find a literature review. The first part is a short review about bile and GS
formation.
The major part though, reviews literature on factors associated with GS in the past. It
was difficult to decide on a structure in which to best present them. This was mainly due
to the fact that most of the studies examined more than one factor in their study. Finally,
I divided the chapter into the main factors and cited every publication that found any
association, be it positive or negative, in the relevant sections. Furthermore I described
most of the studies in more detail. This was done randomly, in different sections of this
chapter, so as to, for example not overload the section on energy intake, which is
mentioned in numerous studies.
2.1 Hepatocyte
The hepatocyte is a highly polarized epithelial cell with a sinusoidal receptor-rich
domain in contact with the plasma, a lateral domain attached to adjacent cells and the
canalicular domain, or apical pole, delimited by tight junctions 1 in contact with bile.
Lipids are secreted through the sinusoidal membrane in the form of lipoproteins and
through the canalicular membrane as monomers (bile acids) and vesicles (phospholipids
[PL], esp. phosphatidylcholine [PC], and cholesterol) 2 3.
                                                                
1 Rigotti et al, 1994
2 Ulloa et al, 1987
3 Cohen et al, 1989
62.2 Bile
2.2.1 Flow and composition
Bile is secreted from the liver into the biliary tree, through which it flows to the
duodenum. In the interdigestive period bile is stored in the GB. Following
cholecystokinin stimulation during digestion bile is delivered in a concentrated form into
the gut1. It is composed of over 90% water and about 10% solutes, mainly biliary lipids
– bile acids (BAs), PL (in bile, mainly as lecithin) and free cholesterol. Other
components of bile include various proteins (albumin, glycoproteins, mucins etc.),
pigment (bilirubin), electrolytes and xenobiotics1 2 3. As mentioned above, cholesterol in
bile is present as free cholesterol. BAs are composed of primary BA (cholic and
chenodeoxycholic acid) and their intestinal de-hydroxylation products (deoxycholic and
lithocholic acid, respectively). All BAs in bile are conjugated with glycine or taurine1.
Biliary PL are composed mainly of PC (~95%) and small amounts of
phosphatidylethanolamine (PE) and phosphatidylserine (PS)4. These PL are a mixture of
molecular species having primarily palmitic or stearic acid in the sn-1 position and less
saturated fatty acyl chains in the sn-2 position5.
                                                                
1 Carey et al, 1988
2 Carey MC, 1989
3 Harvey et al, 1985
4 Angelico et al, 1992
5 Hay et al, 1990
72.2.2 Lipid secretion
An important part of biliary PLs and cholesterol is derived from high density lipoprotein
(HDL) lipids. About 3-20% of biliary PLs and cholesterol are newly synthesized in the
endoplasmic reticulum prior to transport into bile1 2. Patton and colleagues3 suggest that
acyl remodeling of pre-existing PCs as well as hepatic triglyceride (TG) provides most
of the microsomal substrates required for synthesis of bile targeted PCs.
Because of the hydrophobic properties of PLs, these molecules do not move by
spontaneous intracellular aqueous diffusion and must be translocated within the cell,
either associated to lipid binding proteins or in a vesicular form. PL-transfer proteins
have been described and purified4 5 6. The major fraction of cholesterol and PLs transfer
to the canalicular domain of the hepatocyte is believed to be transported by vesicular
movement7 as well as lateral diffusion in the membrane.
The intra-hepatocytic transport of PL-cholesterol vesicles to the canalicular membrane
for secretion into bile has not been elucidated with certainty. Indirect evidence suggests
that a fraction of biliary lipids (de-novo synthesized cholesterol and PLs) originates in a
specific region of the endoplasmic reticulum, where bile-destined lipids are sorted and
packed into intracellular vesicles to be transported vectorially through the Golgi
apparatus and secreted finally into bile8 9.
                                                                
1 Turley et al, 1981
2 Robinson et al, 1988
3 Patton et al, 1994
4 Reinhart, 1990
5 Wirtz KWA, 1991
6 Cohen et al, 1994
7 Crawford et al, 1995
8 Marzolo et al, 1990
9 Coleman et al, 1992
8Monensin, a carboxylic ionophore that was found to interfere with the storage and
transport of proteins from the Golgi apparatus 1, decreased both the sinusoidal secretion
of very low density lipoprotein (VLDL)2 and canalicular secretion of cholesterol and
PL3. Another fraction of biliary cholesterol and PC (preformed lipids) could be
presumably transported to the canalicular region from the endosomal compartment after
processing of lipoproteins internalized by receptor-mediated uptake. Multivesicular
bodies, which are derived from lipoprotein internalization, may be an intracellular
precursor of biliary lipid secretion4. However Cohen and colleagues have shown that
transcytosolic movement of vesicles from the endoplasmic reticulum to the bile
canalicular domain cannot account quantitatively for the flow of membrane PC into bile,
thereby suggesting that both vesicular transport and coupling to lipid-binding proteins
are responsible for the movement of cholesterol and PL to the canalicular membrane 5.
After insertion in the canalicular membrane, PC is thought to reside in micro-domains
that are particularly rich in PC. This assumption is based on the fact that there is a
striking difference between the composition of biliary PL and that of the canalicular
membrane.
Biliary PL contains mainly PC (>95%), whereas the canalicular membrane also contains
sphingomyelin (±20%), PE (±20%), and PC (±20%)6. Furthermore, PC in bile is more
hydrophobic than membrane PC1 7.
                                                                
1 Griffith et al, 1986
2 Rustan et al, 1985
3 Casu et al, 1990
4 Hornick et al, 1985
5 Cohen et al, 1994
6 Yusef et at, 1987
7 Coleman et al, 1992
9Two theories have been proposed to explain the mechanism of biliary lipid secretion at
the canalicular membrane: 1) ‘fusion-budding’ or ‘shedding’1
2) exocytosis2 3.
In view of these mechanisms, PL and cholesterol are coupled tightly to BA secretion
under physiological conditions. The effectiveness of the various BA species in driving
the co-secretory mechanism of biliary PL and cholesterol outputs varies in relation to
their hydrophobicity4 5 6. The quantitative significance of BAs was found to be relatively
minor5. The hydrophobicity of bile acid molecules may have a critical role in the process
of recruiting and sorting cholesterol-PL vesicles.
2.2.3 Cholesterol solubilization
Bile is the only significant pathway for the excretion of cholesterol from the body, and
about half of the biliary cholesterol is lost in feces. The hydrophobic cholesterol is
solubilized in bile at a concentration of 5-15 mM, which exceeds over 100,000 fold its
water solubility.
This solubilization of cholesterol molecules is made possible by the two amphiphilic
lipid molecules – bile salts (BSs) and PL7. Together, the three biliary lipids form
micellar and lamellar-vesicular structures that serve as cholesterol ‘carriers’8 9 10. These
structures incorporate the insoluble cholesterol molecules during bile secretion, flow,
and bile storage in the GB.
                                                                
1 Lowe et al, 1984
2 Evans W, 1981
3 Marzolo et al, 1990
4 Roda et al, 1988
5 Bilharz et al, 1989
6 Hofmann A, 1990
7 Cabral et al, 1989
8 Carey et al, 1978
9 Admirand et al, 1968
10 Somjen et al, 1983 & 1985
10
The sequence of physical-chemical events during lipid secretion into bile is still being
investigated. It is not clear whether PLs and cholesterol are secreted independently or
jointly. Crawford and colleagues1 showed that biliary PL molecules are secreted by
hepatocytes into the bile canalicular lumina as 63 – 67 nm (diameter) unilamellar
vesicles which contains cholesterol. This process is rapid and is facilitated by the
detergent action of BSs at the exoplasmatic part of the canalicular membrane.
Cholesterol is solubilized by vesicles and transported into hepatic bile, which normally
has a cholesterol:PL ratio of about 1:3. In lithogenic bile, which is supersaturated with
cholesterol this ratio is higher especially in the vesicles, where it can reach about 2:12.
During flow in the biliary tree, vesicular cholesterol is gradually taken up into BS rich
micelles. Since mixed micelle formation requires the solubilization of more PLs than
cholesterol, the excess cholesterol remains solubilized in vesicles, which then become
supersaturated and thermodynamically metastable.
2.2.4 Phospholipids (PLs) in bile
Recent evidence suggests that PLs are of major importance in biliary pathophysiology.
Biliary cholesterol is probably secreted as PL vesicles3 4 and PLs are probably the main
cholesterol carriers in the bile5 6. A reduction of biliary PLs by intake of dietary legumes
was associated with an increased cholesterol saturation of the bile7.
                                                                
1 Crawford et al, 1995
2 Donovan et al, 1990
3 Cohen et al 1989
4 Pattison NR, 1985
5 Somjen et al, 1990
6 Gilat et al, 1990
7 Nervi et al, 1989
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During the last decade, some intermediate lamellar structures have also been described
in model and native biles, but their nature and possible role in biliary cholesterol
solubilization and transport is controversial1 2. When BS concentration is sufficient, all
cholesterol will be solubilized in micelles. However, more commonly human bile is
supersaturated and only part of the cholesterol is solubilized in micelles, with the rest
remaining metastable vesicles. When the cholesterol carrying capacity of the lipid
aggregates is exceeded, cholesterol may precipitate and form cholesterol monohydrate
crystals3.
Most available data suggest that biliary cholesterol crystallizes from cholesterol rich
vesicles, though at least one study showed that supersaturated mixed micelles may also
be the source of cholesterol crystal precipitation4. Ultimately, within the GB cholesterol
crystals are agglomerated with an organic matrix of mucin glycoproteins to form
cholesterol GS 5.
2.2.5 Cholesterol crystallization (calculi formation)
Cholesterol monohydrate crystals are microscopic building blocks of cholesterol GSs6.
Hence it is obvious that the process of cholesterol crystallization is a crucial and
obligatory step in cholesterol GS formation.
                                                                
1 Somjen et al, 1990
2 Cohen et al, 1993
3 Small DM, 1980
4 Ahrendt et al, 1994
5 Lee et al, 1979
6 Womack et al, 1963
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This process can be subdivided into 3 successive steps: nucleation, formation and
precipitation of solid crystals (crystallization), and crystal growth1. Despite their
importance, these steps are difficult to observe and investigate separately.
Most research on cholesterol crystallization to date has been based on the nucleation
time assay which measures the crystal detection time in crystal-free bile samples
incubated ex-vivo2. In 1992, Konikoff and his colleagues3 have shown that the process of
cholesterol crystallization is more complex than hitherto believed. Biliary cholesterol
was found to initially crystallize as thin filamentous crystals that transform through
intermediate microcrystalline structures before becoming thermodynamically stable
classical monohydrate crystals. The nucleation time of bile from GS patients has been
shown to be significantly shorter than that of GS free subjects4. This is commonly
interpreted as evidence for the presence of pro-nucleating agents (mainly proteins) in
human lithogenic bile5. On the other hand, normal human biles have longer nucleation
times than identically matched model lipid solutions 6, suggesting the presence of anti-
nucleators in normal non-lithogenic biles. These pro- and anti-nucleating factors have
not all been convincingly documented and there is a great deal of confusion as to their
actual role in GS pathogenesis7.
A clear understanding of the microstructural events occurring during the earliest phases
of cholesterol crystallization in bile is crucial for the identification of factors possibly
delaying or preventing precipitation of cholesterol crystals and therefore, GS formation
in bile.
                                                                
1 Wang et al, 1996
2 Holan et al, 1979
3 Konikoff et al, 1992
4 Burnstein et al, 1983
5 Portincasa et al, 1997
6 Holzbach et al, 1984
7 Harvey et al, 1993
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Carey1 suggests that GSs occur as a result of a change in the proportions of bile lipids in
the bile. Cholesterol saturation or supersaturation in the bile occurs as a result of any of
the two following situations:
 1.  Hyposecretion of BAs (for example due to increased gastrointestinal loss)
 2.  Hypersecretion of cholesterol.
The latter can occur as a result of:
· increased cholesterol synthesis in the liver
· increased consumption of dietary cholesterol
· increased influx of plasma lipo-proteins into the liver.
Supersaturation of cholesterol in the bile leads to precipitation of cholesterol crystals
which favor the development of GSs. Dietary factors might be responsible for
cholesterol supersaturation in the bile, but most probably do not play a role in the
crystallization and/or crystal growth.
2.2.6 Cholelithiasis – formation or presence of calculi (Gallstones, GS) in the GB
This section has been taken from the Merck Manual2.
‘In GS disease we differentiate between cholesterol GS, which are made up of more than
70% cholesterol and pigment stones, made up mainly of calcium salts of bilirubin and
fatty acids (FAs) as well as mucins, and proteins.
GS are formed and located mostly in the GB, but also in the extra-hepatic or intra-
hepatic bile ducts. The site of the GSs can give us information on the make up of the
stones. Cholesterol GSs are mostly found in the GB.
                                                                
1 Carey MC, 1989
2 Beers et al, (pp 400) 1999
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Of the pigment stones, the black stones are usually found in the GB, whereas the brown
stones are bile duct concrements. GSs originally located in the GB can move into the
bile duct.
2.2.6.1 Symptoms and signs
The clinical consequences of GS formation in the GB are exceedingly variable. Most
patients remain asymptomatic for long periods, frequently for life. GS may traverse the
cystic duct with or without symptoms of obstruction. Transient cystic duct obstruction
results in colicky pain, whereas persistent obstruction usually produces inflammation
and acute cholecystitis. In contrast to other types of colic, biliary colic typically is
constant, with pain progressively rising to a plateau and falling gradually, lasting up to
several hours. Nausea and vomiting are often associated. Fever and chills are absent in
uncomplicated GB colic. Pain most often occurs in the epigastrium or right upper
quadrant, radiating to the right lower scapula.
Symptoms of dyspepsia and fatty food intolerance are often inaccurately ascribed to GB
disease. Belching, bloating, fullness, and nausea are equally associated with
cholelithiasis, peptic ulcer disease, or functional disorders. Such symptoms may
disappear after cholecystectomy but should not be the only indication for operation.
Postprandial fatty food intolerance maybe be caused by cholelithiasis if symptoms
include right upper quadrant pain; however, the prevalence of postprandial functional
distress is so high in the general population that these symptoms alone are insufficient
for diagnosis of GB disease without supportive clinical signs and diagnostic studies.
15
2.2.6.2 Diagnosis
Few calculi escape detection, but the relative accuracy, ease, safety, and cost of
diagnostic methods are subject to change, to debate, and to local availability and skills.
US examination is the method of choice for diagnosing possible GB calculi. Sensitivity
(probability of a positive test when disease is present) is 98%; specificity (probability of
a negative test when the disease is absent) is 95%. Static B mode US and oral
cholecystography are also sensitive and specific.
2.2.6.3 Treatment
Asymptomatic GS: Because asymptomatic GS are often discovered during evaluation
of other problems, the question arises whether to recommend observation or elective
cholecystectomy. Neither choice applies to all circumstances. Although the natural
history is unpredictable, there is a cumulative chance (about 2% per year) that symptoms
will develop. Most patients with clinically silent stones decide that the discomfort,
expense, and risk of elective surgery are not worth removing an organ that may never
cause clinical illness, although the potential complications represent serious disease. If
symptoms appear, prompt therapy is advisable.
Symptomatic GS: Biliary colic recurs with irregular, pain-free intervals of days or
months. Symptoms often do not progress in severity or frequency, but neither do they
cease. Symptomatic patients are at increased risk of developing complications, and
cholecystectomy is indicated. Symptoms attributable to the GB can be expected to
disappear after cholecystectomy; nonspecific symptoms of postprandial dyspepsia
usually also remit in patients who have had colic. Recurring colic, even years later,
should prompt an evaluation for possible common duct stones (choledocholithiasis).
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Cholecystectomy does not result in nutritional problems, and no dietary limitations are
required postoperatively.
The standard operation for GB removal through a right subcostal or midline incision is
open cholecystectomy. When performed electively during a period free of
complications, the procedure is relatively safe, with a mortality rate of 0.1 to 0.5%.
However, since its introduction in 1988, laparoscopic cholecystectomy has been the
treatment of choice for symptomatic GS. This technique was popularized largely
because of a shorter convalescence, decreased postoperative discomfort, and improved
cosmetic results. The procedure entails the insertion of specialized surgical instruments
and a video camera into the peritoneal cavity through multiple small incisions in the
abdominal wall. After insufflation of the peritoneal cavity, the GB is removed under
video monitoring. Laparoscopic cholecystectomy is converted to an open procedure in
approximately 5% of cases, usually because of an inability to identify the anatomy of the
GB or to manage a complication.
For patients declining surgical treatment or for whom surgical treatment is inappropriate,
GB calculi may sometimes be dissolved in vivo by giving BAs orally for many months.
Stones must not be calcified, and demonstration of normal GB function on oral
cholecystography is essential. Ursodeoxycholic acid 10 mg/kg/day reduces biliary
secretion of cholesterol and decreases the cholesterol saturation of bile, resulting in
gradual dissolution of cholesterol-containing stones in 30 to 40% of patients. Recurrence
of stones is common after cessation of the drug. Alternative methods of stone dissolution
(methyl- tert-butyl ether) or stone fragmentation (extracorporeal shock wave lithotripsy)
are now largely unavailable owing to greater patient acceptance of laparoscopic
cholecystectomy.’
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2.3 Non Diet-Related Factors associated with GS
Cholesterol GSs are found in 5-30% of the population of Central and Northern Europe,
the USA, Canada, Australia and New-Zealand and in 70-90% of people suffering from
GSs1. Geographical and ethnic factors, together with gender and age differences, seem
to be major risk factors in the etiology of cholelithiasis2.
2.3.1 Geographic and ethnic influences
Genetic and ethnic influences can be observed, especially in North America, where 70%
of Pima Indians in Arizona suffer from GS 3. Regarding both sexes, significantly more
GB disease was found in the Indians than in the population of Framingham,
Massachusetts. No association was apparent between either body weight or serum
cholesterol and GB disease in the Pima group2. This is different from findings in other
populations, discussed later. Though genetics have been suggested as the cause in this
case, no genetic marker could be identified so far.
Comparison of the number of GB operations carried out in 1961 and 1971 in three
similar towns in Canada, England, and France suggests that the incidence of GB disease
was six times higher in North America than in Western Europe and nine times higher for
patients below the age of 35. The number of cholecystectomies had doubled in all three
countries over ten years4. The operation rate, however, does not reliably reflect
prevalence rates.
                                                                
1 Sama et al, 1990
2 Bennion et al, 1978
3 Comess et al, 1967
4 Plant et al, 1973
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Chileans also have a higher risk of GS disease1. Further in Chilean Indians and
Hispanics cholesterol lithogenic genes are widely spread and this might explain the high
prevalence of GB diseases among some South American populations 2.
A study on Mexican Americans3 was based on the San Antonio Heart Study, a
population-based survey whose phase one was performed between 1979 and 1982,
which assessed cardiovascular risk factors and health status in a bi-ethnic sample of
Mexican Americans and non-Hispanic whites, aged 25-64 and non-pregnant women.
The participants were randomly selected from three neighborhoods. The participants
were questioned about any history of GB disease and interviewed to determine their
dietary intake using the 24-hour recall method. This was followed by a medical
examination in a mobile clinic, including skinfold measurements. Even after adjusting
for differences in dietary intake between the ethnic groups Mexican American women
had a higher risk of GS disease.
                                                                
1 Covarrubias et al, 1984
2 Miquel et al, 1998
3 Haffner et al, 1989
19
2.3.2 Demographic differences (age and gender)
The prevalence of GSs is approximately two times higher in women than in man. This is
true for ages between puberty and menopause, after which the difference in prevalence
between females and males narrows.
In a study conducted on Caucasian women from a rural Canadian community, the
authors documented a relatively high prevalence of GSs (11.3%) in young Caucasian
women (20-50 years of age), with a peak prevalence in the fourth decade of life (33%)1.
In this population the risk factors identified were obesity, a narrow range of daily energy
intake, a low daily calcium intake and a low level of activity.
The GS prevalence was studied in 11, 840 consecutive autopsies from 1940-1975 in the
University hospitals of Essen, Germany. The total prevalence was 20.7%, 13.1% for
men and 33.7% women. The crude prevalence for three 12-year periods showed a
significant increase from 8.2% to 15% in men, and from 25.7% to 36.3% in women. A
detailed analysis showed that this increase occurred only in the age groups over 60 and
was the consequence of the fact that a greater proportion of women over 60 came to
autopsy. When age and gender-specific morbidity ratio was calculated to standardize the
data, the authors found considerable fluctuations in 3-year periods since 1940, and
therefore concluded that there was no real increase in the prevalence of GSs in the past
30 years2.
                                                                
1 Williams et al, 1980
2 Balzer et al, 1986
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The prevalence of GS disease (cholelithiasis and previous cholecystectomies) in the
population of the town of Sirmione, Italy, was examined by US examinations, was 6.7%
in men, and 14.6% in women, ranging from 18 to 65 years af age (overall prevalence =
11%)1. The prevalence of cholelithiasis in the same age span was 6.9% (4.5% in men
and 8.9% in women). Prevalence of cholelithiasis increased with age in both sexes.
Prevalence of GS disease was found to be higher in obese and hypertriglyceridemic
subjects and to increase with the number of pregnancies1.
The prevalence of GS disease in a large Romanian town was determined on 6275
necropsies performed during a 10-year period (1973-1982). The crude prevalence of GS
disease in women was 17.1% and 6.9% in men. Age-standardized prevalence was 8.4%
in women and 5% in men. This rate is lower than the prevalence of GSs in Northern or
Central European countries, but it is higher than that established in some Southern
countries of Europe. A comparison of the crude prevalence of GS disease was compared
with that calculated for a similar 10-year period 100 years ago (1873-1882), on 1538
necropsies performed in the same town. Prevalence of GSs rose significantly in a
century from a mean of 1.2% to 11.3%, a finding consistent with the concept that GS
disease is a “disease of civilization”2.
Overall prevalence in a population of male civil servants in Rome was 8.2% and
increased with age from 2.3% in the 20- to 25-year-old age group to 14.4% in the 60– to
69-year-old age group, based on both presence of GSs and history of cholecystectomy3.
                                                                
1 Barbara et al, 1987
2 Acalovschi et al, 1987
3 GREPCO 1988
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One hundred elderly black women in Soweto, aged 55 – 85, who had no clinical
evidence of gastrointestinal (GI) disease underwent US. 10 patients were positive for GS
(10%). The body mass index (BMI) was significantly higher in the GS carriers, although
no differences were found in nutritional habits (using the 24-hour recall method)1.
The prevalence of GS disease in Maastricht was studied by US screening of a hospital
population of 424 men and 631 women, admitted for elective surgery unrelated to GS
disease. The prevalence increased with age. In the oldest age category (70-79 years of
age) 16% of the men and 40% of the women had GS disease. These prevalence data are
on the lower side within the range of prevalences found in other West European
countries2.
The prevalence of GS disease in a stratified random sample of 1896 British adults was
established using real time US (performed for the purpose of the study just after having
been enrolled). The prevalence rose with age, except in women of 40-49 years, so that at
60-69 years, 22.4% of women and 11.5% of men had GSs or had undergone
cholecystectomy3.
A total of 29 739 Italians were screened in the MICOL study. 6.5% of the males, and
10.5% of the women had GS. Prevalence of GS disease (GSs and cholecystectomy)
increased linearly with age in both sexes4.
                                                                
1 Walker et al, 1989
2 Thijs et al, 1990
3 Heaton et al, 1991
4 Attili et al, 1995
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2.3.3 Parity and hormonal intake
The number of births, as well as the intake of estrogens in the form of birth control pills
and/or estrogen preparations often taken after menopause, are said to increase the
cholesterol saturation in the bile and thereby increase the risk of cholesterol GS
formation1. Gilat and Konikoff2 believe that the controversies regarding the true
relationship of pregnancies and GS disease, in the past, were mainly due to disregarding
of potential confounders. They argue that comparisons should have only been made
within a defined population having similar genetic and environmental backgrounds, with
the number of pregnancies being regarded as the major variable. In 2000 they analyzed
some more recent publications that had much more uniform results. These included The
Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO) study3,
which investigated employees of government ministries in Rome, the Sirmione study4,
which evaluated inhabitants of a village in northern Italy, and a study performed in
Denmark5, investigating a random sample in Copenhagen county. All three studies
described a two to three times higher crude prevalence of GSs in women with two to
three or more pregnancies compared with nulliparous women. Other studies have also
provided some evidence that multiple pregnancies are actually a risk factor for the
development of GS, nevertheless their adjustments regarding potential confounding
factors were not uniform4 6 7 8 9.
                                                                
1 Scragg et al, 1984
2 Gilat et al, 2000
3 GREPCO, 1984
4 Barbara et al, 1987
5 Jørgensen T, 1988
6 Friedman et al, 1966
7 Comess et al, 1967
8 Attili et al, 1997
9 Singh et al, 2001
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In Benha City1, neither age of menarche, duration of menstrual life, age at first
pregnancy, multiparity nor duration of contraceptive pill use showed any differences
between the female cases and controls studied. Jørgensen2 described significant
associations with young age at menarche, abortions and multiple childbirth.
Pixley and colleagues3 could neither prove an association between parity nor exogenous
hormones with GS disease in vegetarian women. Wheeler’s group 4 could observe a
higher risk with pregnancy and GS disease. They suggested that pregnancy could have
had an influence on dietary intake, and thereby on the subcutaneous fat, but this will
remain unknown as the participants were not asked about change in dietary habits during
pregnancy.
In a CCS in Australia5 it was observed that contraceptive use increased the risk of GS
development in young women, whereas decreased it in the older females. It was also
observed that risk increased with increasing parity especially among the young women.
The risk fell with progressing age at first pregnancy, independent of parity. The authors
suggested that there were subpopulations of women susceptible to early formation of
GSs after exposure to either oral contraceptives or pregnancy. An Italian study in
Castellana 6 observed an increased risk with pregnancy.
                                                                
1 Abdel-Rahman et al, 1993
2 Jørgensen T, 1988
3 Pixley et al, 1985
4 Wheeler et al, 1970
5 Scragg et al, 1984
6 Misciagna et al, 1996
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2.3.4 Metabolic diseases
People suffering from DM were shown to have a higher risk for cholelithiasis, though
the mechanism remains unknown. Although there was no association between DM and
GB disease in Pima females, an association between these diseases was actually present
in older Pima males1. Between 1986 and 1990 screening US of the GB was performed in
2,756 male self-defense officials in Japan who received a retirement health
examination2. Risk factors were investigated in 61 men with GSs and 38 with previous
GB removal (overall prevalence of 3.6%). DM could not be associated with GS disease
in this setting.
101 newly diagnosed GS carriers identified from a small town in Italy were matched to
303 controls3. It was found that even in subjects with no clinical diagnosis of DM,
insulin was associated with GSs.
2.3.5 Gastrointestinal (GI) diseases
Several GI diseases seem to predispose cholelithiasis. This was shown for diseases of
colon and ileum4 5, as well as subjects suffering from cystic fibrosis 6 7 8 9 and people
suffering from bile malabsorption7. In gastrectomized patients the GB volume was
significantly increased10.
Heaton11 suggested in a review article that the role of colonic transit may play an
important role in the etiology of GS formation.
                                                                
1 Comess et al, 1967
2 Kono et al, 1992
3 Misciagna et al, 2000
4 Nightingale et al, 1993
5 Andersson et al, 1987
6 Jebbink et al, 1992
7 Henschke et al, 1983
8 Bennion et al, 1987
9 L’heureux et al, 1977
10 Hahm et al, 2000
11 Heaton KW, 2000
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He based his suggestion on a number of studies which proved high prevalence in people
with high usage of laxatives (indication for constipation) and in people with high biliary
deoxycholic acid (DCA) (colonic BA)1, and on studies which proved slow transit in non-
obese GS carriers2. Enrichment of bile with DCA leads to enrichment of the bile with
cholesterol. Biliary DCA can be raised and lowered by slowing down and speeding up
colonic transit, respectively.
Dowling and his group 3 showed in patients receiving octreotide that slow large bowel
transit increases the production (and absorption) of DCA and are lithogenic.
Furthermore in acromegalic patients, octreotide increased the proportions of arachidonic
acid-rich phospholipids, with associated rises in (a) the cholesterol saturation index and
percentage of vesicular cholesterol, and (b) the percentage of DCA in GB bile4.
2.3.6 Physical activity
As part of the Nurses Health Study, a sub-study investigated recreational physical
activity and sedentary behavior in relation to the risk cholecystectomy in females5. Out
of 60,290 women who were 40-65 years of age in 1986, 3257 cases of cholecystectomy
were identified. Analysis of the questionnaires on physical activity that was mailed
every 2 years showed that recreational physical activity (such as jogging, running,
cycling) was associated with a decreased risk of cholecystectomy (Relative Risk [RR]:
0.69).
                                                                
1 Petroni ML, 1996
2 Spathis et al, 1997
3 Veysey et al, 1999
4 Pereira et al, 2001
5 Leitzmann et al, 1999
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Women who spent between 41-60 hours sitting per week as compared to those who sat
less than 6 hours per week while at work or driving, showed an increased risk of 1.42.
The risk-association was strengthened in women who sat more than 60 hours per week
(RR: 2.32). The association persisted when controlled for body weight or weight
changes.
With regard to men, 828 male symptomatic GS carriers were identified after a 8 year
prospective, follow-up study of 45,813 health professionals, aged 40-75 in 19861.
Physical activity was assessed by analyzing five questionnaires that were mailed every
two years. Increased physical activity was inversely related to symptomatic GS disease,
where the association was stronger in those younger than 65, than in the older group
(RR: 0.58 and 0.75, respectively). In contrast, sedentary behavior (more than 40 hours
watching TV per week) was associated with an increased risk. The RR in the older
group was 3.32, in the younger ones the association was somewhat less prominent with
an increased risk of 1.58.
2.3.7 Smoking habits
A matched CCS performed on 96 cases and 118 age- and gender matched controls2
actually found smoking as well as jobs demanding hard labor to be protective. In
Australia3 it was observed that current-smokers versus never-smokers had an increased
risk of 1.3 in females and 1.6 in males. It was further shown that current-smoker
females, less than 35 of age, had an increased risk of 3.5, and women who had been
smoking for 1-8 years increased their risk by 2.8.
                                                                
1 Leitzmann et al, 1998
2 Linos et al, 1989
3 McMichael et al, 1992
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It was concluded that smoking-related risk was greatest soon after first exposure, which
might be an indication that exposure factors could be different between early-occurring
and late-occurring cases. In Italy1 smoking was found to be associated with risk of GSs.
2.3.8 Serum lipids
Barbara and colleagues2 found that hypertriglyceridemic but not hypercholesteremic
patients were at higher risk. Nevertheless, a Japanese study3 could not confirm any
relation, neither positive nor negative, between serum TGs and total serum cholesterol
and GS disease. Tandon4 demonstrated in a study in Northern India that female and male
GS carriers had significantly higher TG values, whereas only the male cases had
significantly higher serum cholesterol levels than their controls. In an Italian study5 it
was observed that young women with GSs were slightly hypercholesteremic as
compared to non-carriers.
                                                                
1 Misciagna et al, 1996
2 Barbara et al, 1987
3 Kono et al, 1988
4 Tandon et al, 1996
5 Cavallini et al, 1987
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2.4. Diet-Related Risk Factors associated with GS
The following section is partly based on the article published by Trautwein1, in which
the author reviewed a substantial number of studies that examined dietary factors in the
development of GS disease. It has been updated and augmented by additional, old and
new studies.
Epidemiological studies which have examined the relationship between lifestyle and/or
dietary habits and cholesterol GS, including CCSs which compared dietary habits of
patients suffering from GSs with those of healthy “stone-free” individuals, as well as
examinations aimed particularly at the impact of nutrients on cholesterol saturation of
the bile, have provided valuable information about that relationship. The most important
putative dietary risk factors are increased caloric intake, as well as elevated intake of
cholesterol and fat (especially of animal origin). Simple carbohydrates and saccharine
also seem to play a part as well as obesity and dieting. However, vegetable protein,
dietary fiber and alcohol seem to have an inverse relationship to the development of
GSs.
The importance of CCSs lies in the fact, that dietary habits of study subjects can be
compared to those of disease-free individuals, which provide a picture on the dietary
impact on the disease being studied. Many or most of the published CCSs dealing with
the impact of dietary factors on cholelithiasis are subject to methodological deficiencies.
                                                                
1 Trautwein EA, 1994
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They contained either a small number of study subjects, or GS status was not ascertained
properly, or an unsuitable control group (hospital-based controls suffering from other
diseases) was selected. Often the cases examined were symptomatic. In this context it is
also important to remember that patients often change their eating habits after their
knowledge of their GSs. Therefore when conducting CCSs some patients might have
already changed their dietary habits prior to being questioned about their usual intakes,
and will find it hard to reconstruct their diet prior to knowledge of the disease.
Additionally many of the studies published had questionnaires containing only a narrow
variety of foods. Others used 24-hour or 48-hour diet recall methods, which do not
provide a true picture of usual dietary intake habits.
There have been a great number of intervention studies in humans and also in animals,
in which the effect of specific dietary components on the bile; its lipids, as well as on
cholesterol saturation was evaluated. In particular, the influence of total energy intake,
the amount of fat intake as well the FA composition (especially of polyunsaturated fatty
acids [PUFAs]), the cholesterol intake and the dietary fiber intake were examined. In
those kinds of examinations care needs to be taken regarding the interactions among the
nutrients, which make it difficult to differentiate which single nutrient exerted the effect.
For example, the intake of one nutrient often goes together with the intake or reduction
of another one:
ü a high intake of simple sugars comes often with a decreased intake of complex
carbohydrates and dietary fiber
ü the intake of animal fat goes along with intake of animal protein
ü the consumption of animal fat also means consumption of cholesterol etc.
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2.4.1 Increased energy intake and obesity
Sarles and his colleagues were a group of scientists who pioneered the research on the
etiology of GS disease. Their first matched case- control study1 included 101 female
patients, aged 20-55, with GSs, and 101 age-matched controls, of the same race, with a
similar profession (or husband’s occupation). Presence of GSs was proven by operation
and/ or radiology. Of the 101 patients, 56 were operated on and they were ascertained to
have cholesterol GSs. Controls did not undergo cholangiography, and therefore some of
them might have had ‘silent’ stones. The questionnaire consisted of 141 questions on the
way of life. Questions on dietary habits for one week before the onset of the disease, or,
if silent, before the diagnosis were asked during the first interview. A second interview
took place either after the first attack, the diagnosis of disease, or the surgical operation,
and all modifications of the usual dietary habits were noted. Taking their previous two
studies (1959 and 1965) into consideration, the authors finally concluded, that, as in
each study the methodology slightly differed, different dietitians interviewed the
participants, and the studies took place at different points in time, an increased caloric
intake irrespective of the composition of diet and the weight of the patients, was a cause
of GS formation. In two later studies2 the progressive decrease of differences found in
the three previous studies of Sarles et al was confirmed. They therefore concluded that
the over-consumption of total energy, mainly foods of animal origin, in France in the
aftermath of World War (WW) II was a risk factor, whereas starvation during WW II
was protective against cholesterol GS disease.
                                                                
1 Sarles et al, 1969
2 Sarles et al, 1978
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In the Nurses’ Health Study1 a prospective cohort study 88,837 US nurses, aged 34-59
years, completed a semiquantitative (61 items) food frequency questionnaire (FFQ) in
1980 and were without prior diagnosis of cholelithiasis or prior symptoms later
attributed to cholecystitis. Women were asked to report diagnoses of GSs or
cholecystectomy on follow-up questionnaires sent in 1982 and 1984. Many articles have
been published from the results of this study, with regard to a large number of different
diseases and factors.
The authors referred to those subjects included as symptom-associated GS carriers,
though recognizing that they might have included a presumably large number of
asymptomatic, ‘silent’ GS carriers having GI symptoms due to other causes. Their
results have to be taken with caution due to potential bias in their study design. Potential
bias due to only having examined nurses is very probable, as the nurses are not a
representative sample of the population at large. They are highly motivated women, with
health education and awareness of a healthy life style. Secondly, the study included
women only. Most importantly the study excluded the great majority of asymptomatic
GS carriers. Nevertheless the authors argued that in their opinion, there could not be bias
of food intake as the data was collected before onset of disease. It was observed that
high energy intake in itself appeared to be a significant risk factor for symptomatic GS
disease. This association was also observed in Northern India 2 and in Mexican
Americans 3.
                                                                
1 Maclure et al, 1989 & 1990
2 Tandon et al, 1996
3 Tseng et al, 2000
32
A great number of studies have managed to provide us with data that strengthen the
hypothesis that obesity increases the risk of GS development  1 2 3 4 5 6 7. The relation
between obesity and GSs was shown to be more noticeable in women, than in men6 8,
and specifically in women under the age of fifty8. Haffner and his colleagues9 went even
further and examined the distribution of fat in the body. They found that the risk was
higher in women who were classified as having a central fat distribution, as opposed to
overall adiposity. Obese people were shown to actually suffer three-to-four times more
often from cholesterol GS disease than normal weight individuals.
Nevertheless, there are studies that could not find an association between GB disease
and increased weight10.
As weight is very relative, it is more accurate to take into consideration the height and
age of the subjects. Therefore the studies which have proven a direct correlation between
BMI and GS disease, might be a little more conclusive regarding the influence of
obesity5 11 12 13 14. Since obesity itself is an important risk factor for GS formation, it is
rather difficult to differentiate between the influences of obesity and those of
hypercaloric dietary habits. Nevertheless there were studies that found a correlation with
obesity, but no difference in nutrient intake between cases and ‘stone-free’ subjects10.
                                                                
1 Williams et al, 1980
2 Barbara et al, 1987
3 GREPCO 1988
4 Maclure et al, 1989
5 Maclure et al, 1990
6 Sichieri et al, 1991
7 Stampfer MJ, 1992
8 Scragg et al, 1984
9 Haffner et al, 1989
10 Comess et al, 1967
11 Walker et al, 1989
12 Kono et al, 1992
13 Kodama et al, 1999
14 Misciagna et al, 1999
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2.4.2 Dieting
Dieting however, which in general is the healthiest cure to obesity, does not necessarily
protect from the development of GSs. In studies that examined obese people who tried
to lose weight, a marked increased incidence in cholesterol GS disease could be
observed1 2 3.
A weight reduction with an average loss of 16.5 kg led to GS formation in 25% of the
obese participants (women and men) who ate an energy-reduced diet (500 kcal per day)
for a period of eight weeks1. In most of the cases the asymptomatic GSs disappeared and
the cholesterol saturation of the bile normalized after reaching ‘normal weight’.
Nevertheless in 20% of the cases GS disease was symptomatic1. Another study of this
kind showed that not only the period of dieting but also the degree of obesity and loss of
weight as well as the plasma TG concentration, increase the risk of GS development3.
On the other hand, a Dutch CCS found a stronger co-relation between BMI and the risk
of GSs rather than between dieting and GSs4. In that study the influence of dieting on
GS disease was strongly dependent on the pre-dieting BMI, where the influence
decreased with increased obesity. An increased GS risk was observed in thin people with
a BMI between 14 and 21, whereas with obese people there was no increase in risk.
Therefore the authors of this study concluded that diets for the obese do not increase the
risk of GSs in the long-term.
In the ‘Nurses Health Study’ 5 it was also observed that dieting had more of a moderate
effect on the risk of symptomatic GSs. The influence of adipositas as a risk factor was
markedly higher than the influence of dieting.
                                                                
1 Liddle et al, 1989
2 Sichieri et al, 1991
3 Yang et al, 1992
4 Thijs et al, 1992
5 Stampfer et al, 1992
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2.4.3 Influence of fats (refer to table 2.1)
The direct influence of fat intake on bile lipids and GS incidence in humans is not
entirely clear. Studies concerned with the question of how dietary fat has an influence on
the development of GSs, examined on the one hand the effect of the amount of total
dietary fat intake and on the other hand the influence of specific FAs, especially the
proportion of PUFAs. In almost all of the studies, which examined the influence of total
fat on bile lipids, fat was substituted with carbohydrates. Since the proportion of fat and
carbohydrates have been changed at the same time, it is difficult to decide which of the
two nutrients has brought about the change in the bile lipid composition. In this context
it is rather interesting that such a diet leads to elevated serum TG concentrations and
lowers HDL-cholesterol concentrations, which have also been mentioned as risk factors
for the development of cholesterol GSs.
Studies which examined the influence of fat quality, especially the effect of PUFAs on
the bile lipids showed inconsistent results. In a dietary study for the prevention of HD
conducted in Los Angeles, it was observed that men ingesting a diet high in PUFAs, had
double the GS prevalence than men who continued with their typical American diet. In
other studies it was observed that in men, but not in women, a high PUFA intake
elevated the secretion of cholesterol in the bile. In epidemiological studies no influence
of dietary fat or FA composition on bile lipids was observed. In the ‘Nurses Health
Study’ it was observed though, that women ingesting a diet high in PUFAs had a
decreased risk of developing symptomatic cholelithiasis.
Summarizing the effect of PUFAs, there seems to be a gender difference in terms of the
influence, with a higher risk for men than women.
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Table 2.1: Influence of fat & cholesterol intake on bile lipids &/or risk of GS disease
TYPE OF FAT EFFECT LITERATURE
Total fat Risk elevated with increased fat intake
Risk elevated with increased fat intake (males)
No effect found
1
2
3 4 5
Animal fat Risk elevated with increased animal fat intake 6
Vegetable fat Protective effect of vegetable fat 7 8
Saturated fat Risk elevated with increased fat intake 9
PUFA Risk elevated with high intake of PUFA
(especially in men)
Risk decreased in women with high intake of
PUFA
No effect of PUFA (especially in women)
4 10 11
7
12 13 14
MUFA Protective effect (also from olive oil) 6, 9
Dietary
cholesterol
Increase of biliary cholesterol saturation
Protective effect through dietary cholesterol
No effect through dietary cholesterol
15 16
9
8 10 17 18
Adapted from Trautwein, 1994 and modified
                                                                
1 Diehl et al, 1987
2 Tandon et al, 1996
3 Miettinen et al, 1976
4 Bennion et al, 1978
5 Sichieri et al, 1991
6 Linos et al, 1989
7 Maclure et al, 1990
8 Pixley et al, 1985
9 Misciagna et al, 1999
10 Diehl et al, 1989
11 Sturdevant et al, 1973
12 Dam et al, 1966
13 Kohlmeier et al, 1985
14 Kohlmeier et al, 1988
15 Den Besten et al, 1973
16 Lee et al, 1985
17 Comess et al, 1967
18 Scragg et al, 1984
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2.4.4 Dietary cholesterol intake
At present the role of dietary cholesterol in the etiology of GSs is not entirely clear. The
results of studies done so far are inconsistent. Examinations in humans, who had
consumed great amounts of cholesterol, did not show a correlation between dietary
cholesterol and cholesterol saturation in the bile1 2. Contrary to this two other studies
found an elevated cholesterol saturation associated with an increased consumption of
dietary cholesterol3 4.
CCSs and studies based on population differences do not give a clear indication for a
correlation between cholesterol GS and the intake of dietary cholesterol5 6. In the
‘Adelaide study’ the authors even found in young women a negative correlation between
cholesterol intake and development of GS6.
A large cross-sectional study including 1081 female civil servants in Rome7 aimed to
investigate relations between type of dietary fat habitually consumed and risk of GS
development by comparing the erythrocyte FA composition of women with and without
GSs. The GB status was determined by US and/or oral cholecystography. Determination
of red blood cell FA pattern has been demonstrated to be an objective index of FA
composition of habitual diet over a long period. The results did not demonstrate
significant differences between the study groups. The authors suggested that dietary fats
might not play a major role in the etiology of cholelithiasis.
                                                                
1 Andersen et al, 1979
2 Dam et al, 1971
3 Den Besten et al, 1973
4 Lee et al, 1985
5 Diehl et al, 1989
6 Scragg et al, 1984
7 Arca et al, 1987
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Misciagna and colleagues1 conducted a CCS on 100 newly diagnosed GS carriers to
whom they matched 290 population-based controls. The presence of GSs was
ascertained by US examination. The usual diet and physical activity was recorded by
self-completion of a questionnaire. They observed a positive association between GSs
and dietary cholesterol intake.
2.4.5 Protein intake and quality
Concerning protein intake as well as protein quality, there is not much known about an
association with GSs. The MICOL study showed a slight positive association with total
protein intake only in their male subjects2. Nevertheless it was observed that vegetarians
have only half the incidence of GSs than non-vegetarians 3. The Nurses Health Study4
also concluded that protein of plant origin might have a protective effect on the risk of
symptomatic GSs. Here care must be taken, as the authors could not clearly differentiate
between an effect of vegetable protein and an effect of vegetable fat or a higher
consumption of dietary fiber.
A study on Chilean men5 showed that intake of legumes elevated the cholesterol
saturation significantly in the bile, but the exact mechanism is not understood.
                                                                
1 Misciagna et al, 1999
2 Attili et al, 1998
3 Pixley et al, 1985
4 Maclure et al, 1990
5 Nervi et al, 1989
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2.4.6 Carbohydrate intake
Epidemiological examinations suggest that an increased consumption of simple
carbohydrates increase the risk of GSs1 2 3. In the Adelaide Study3 it was found that the
consumption of foods containing sugars, such as soft drinks and sweets was higher in
GS patients than in the control groups. A study in Northern India 4 found that intake of
refined carbohydrates was significantly higher among the female cases as compared to
their controls, whereas a significantly higher total carbohydrate intake in cases compared
to their disease-free controls was true for both sexes. The Nurses Health Study5 and a
study in vegetarians 6 on the other hand, could not find any relation between total
carbohydrate intake and GSs. The MICOL study found a slight positive association with
total carbohydrates in males and females7.
                                                                
1 Misciagna et al, 1999
2 Diehl et al, 1989
3 Scragg et al, 1984
4 Tandon et al, 1996
5 Maclure et al, 1990
6 Pixley et al, 1988
7 Attili et al, 1998
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2.4.7 Dietary fiber
In a CCS in Adelaide1, 267 hospitalized patients with cholelithiasis, proven by US or
cholecystography were matched to 241 controls from the community (no US
examination) and 359 hospital controls who had also undergone US. Subjects were
below 70 years of age. They underwent a first interview for medical history and
demographics (double-blind), then filled out a self-administered quantitative FFQ
containing 105 items, which was followed by a double-blind check-up interview. They
found an inverse association between GS and dietary fiber intake that presumably would
have been stronger had they adjusted for energy intake. Attili and his colleagues2 found
a negative association with the intake of dietary fiber in the female subjects. In another
Italian CCS3 an inverse association was observed between dietary fiber from cellulose
and the presence of GSs. In yet another study, no effect was observed4.
2.4.8 Drinks (incl. alcohol)
Alcohol, which is known to elevate the concentration of HDL-cholesterol, has most
probably an effect on cholesterol concentration in the bile5. In epidemiological studies it
was observed that the risk of GSs decreases with the consumption of alcohol1 6. In the
Nurses Health Study the consumption 5g and more alcohol per day was related to a 40 %
decrease in GS risk in obese women7.
                                                                
1 Scragg et al, 1984
2 Attili et al, 1998
3 Misciagna et al, 1999
4 Nervi et al, 1989
5 Thornton et al, 1983
6 Kono et al, 1992
7 Maclure et al, 1990
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As part of a health professional follow-up in the USA, 46 008 men, aged 40-75 in 1986
and with no history of GSs, self reported food and drink intake by completing a FFQ for
follow-up until 19961. The authors went further than just assessing alcohol consumption
in relation to symptomatic GS disease, it also aimed to assess alcohol consumption
patterns and specific types of alcohol. Consumption patterns that reflected any amount
of intake 5-7 days per week was associated with a decreased risk of symptomatic GSs as
compared to non-drinkers. In contrast, infrequent consumption (up to 2 days per week)
showed no association with risk. All types of alcohol were inversely related to the risk of
symptomatic GS disease.
In the same prospective study, the caffeine intake was assessed and the results published
elsewhere2. After controlling for known or suspected risk factors, the RR for men in the
highest category of caffeine intake (>800 mg/d) compared with men in the lowest
category (£25 mg/d) was 0.55. In contrast decaffeinated coffee was not associated with a
decreased risk of symptomatic GSs.
Misciagna et al3 found that wine and coffee were protective in GS disease.
                                                                
1 Leitzmann et al, 1999
2 Leitzmann et al, 1999
3 Misciagna et al, 1996
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2.4.9 Vegetarianism
In a CCS, 109 non-vegetarian GS carriers and only 12 vegetarian GS carriers were
matched to GS-free subjects according to age 1. Most cases were recently identified,
though 31 were post-cholecystectomy. Participants had to complete a four-day fixed
format dietary diary. Within a month of completing the diary the subjects were
interviewed by one of the two specially trained interviewers to clarify any discrepancies
in the diary and to collect further clinical information, such as weight and height. An
appreciably reduced frequency of GSs was found in vegetarians as compared with non-
vegetarian women (11.5% and 24.6%, respectively), eating a more typical Western diet,
though the nutrient intake did not differ between cases and controls. When considering
nutrient intakes for non-vegetarians and vegetarians, however striking differences
emerged. Non-vegetarians had a significantly higher consumption of total calories, total
protein, total fat, cholesterol, and alcohol. On the other hand they had a significantly
lower intake of non-animal (vegetable) protein, total carbohydrates, refined sugars,
dietary fiber. Cases were significantly more obese as measured by the BMI. Considering
the response rate of 69%, non-responder bias could be considered. Also an appreciable
under-estimation of intake by the obese might be possible.
                                                                
1 Pixley et al, 1988
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3. METHODS
3.1 Case Control Studies (CCSs)
Cohort and case-control methodologies are the main tools for analytical epidemiological
research. Other important types of epidemiological studies mainly for generating
hypotheses include cross-sectional and ecological, or correlation studies. The
conclusions that can be drawn from findings of these types of studies are, however,
much weaker compared to those of cohort and CCSs. This is not to say that findings
from cohort and CCSs always reflect true associations which can be universally
generalized. Epidemiological research is, to a large extent, of an observational character
as opposed to experimental research.
The study discussed in this thesis is known as a CCS. The cases’ history of exposure or
other characteristics, or both, prior to onset of the disease, is recorded by interview and
sometimes referring to records and other sources. A comparison group consisting of
individuals without the disease under study but similar in other pre-specified criteria
(controls) are selected, and their past history is recorded in the same fashion as for the
cases. The purpose of the control group is to provide an estimate of the frequency and
amount of exposure in subjects in the population without the disease being studied. This
means that whereas cohort studies are concerned with frequency of disease in exposed
and non-exposed individuals, CCSs are concerned with the frequency and amount of
exposure in subjects with a specific disease (cases) and people without the disease
(controls).
3.1.1 Measure of association
In CCSs, data are not available to calculate the incidence rate of the disease being
studied, and the actual RR cannot be determined.
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The measure of association between exposure and occurrence of disease in CCSs is the
so-called odds ratio (OR): the ratio of odds of exposure in diseased subjects to the odds
of exposure in the non-diseased. The following table exemplifies the basic method of
calculating the OR in a CCS.
Table 3.1: Basis of calculating ORs in CCSs
DiseaseExposure
Yes (cases) No (controls)
Yes a b
No c d
Odds of exposure a/c b/d
The OR is thus given by 
]/[
][
db
ca
 (or ad/bc). The OR is generally a good estimate of the
relative risk. The terms OR and RR are in fact interchangeable when used in CCSs.
3.1.2 Confounding and bias
As mentioned earlier, CCSs are observational studies and are potentially subject to the
effect of extraneous factors which may distort the findings of these studies. The term
confounding (or confounding factor) used in this context refers to an extraneous variable
that satisfies both of two conditions: it is a risk factor for the disease being studied, and
it is associated with the exposure being studied but is not a consequence of exposure1.
                                                                
1 Schlesselman JJ, 1992
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Adjusting for the effects of confounding factors is evidently important in observational
epidemiological studies, and can be dealt with in the study design by matching or
stratifying sampling of study subjects, or in the data analysis by stratification or
multivariate analyses1 2 3.
Another potential complicating factor of not only observational but practically all types
of research, is bias. Bias has been defined as any systematic error in the design, conduct,
or analysis of a study that results in a mistaken estimate of an exposure’s effect on the
risk of disease1. Sackett4 has provided an extensive discussion of various types of bias.
One type of bias frequently referred to in epidemiological research is “recall bias”,
namely the propensity of diseased subjects (cases) when interviewed, to scrutinize their
memory and report more accurately on past exposure and possible causes of their
disease than non-diseased subjects (controls) would do. Such recall bias has been
documented5 6 7.
                                                                
1 Schlesselman JJ, 1992
2 Kleinbaum et al, 1982
3 Rothman KJ, 1986
4 Sackett DL, 1979
5 Hogue CJ, 1975
6 Klemetti et al, 1967
7 Lindefors-Harris et al, 1991
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3.1.3 Advantages and disadvantages of CCSs
When faced with a research question concerning the association between a possible
etiologic factor and disease, the epidemiologist has to choose an appropriate strategy to
resolve the matter. A number of circumstances have to be considered before a certain
type of research is chosen, such as the incidence rate of disease, time elapsing between
exposure and clinical manifestation of the disease, whether the exposure is associated
with only one or more diseases, the urgency of the research question, ethical issues, and
funding available for the research, etc. Below are listed some of the advantages and
disadvantages of CCSs.
Table 3.2: Advantages and Disadvantages of CCSs
Advantages Disadvantages
J Permit the study of rare diseases L Information on exposure and past history is
primarily based on interview and may be
subject to recall bias
J Permit the study of diseases with long
latency between exposure and
manifestation
L Validation of information on exposure is
difficult, or incomplete, or even impossible
J Can be launched and conducted over
relatively short time periods
L By definition, concerned with one disease
only
J Relatively inexpensive as compared
to cohort studies
L Generally incomplete control of extraneous
variables
J Can study multiple potential causes of
disease
L Choice of appropriate control group may
be difficult
L Correct interpretation of results may be
difficult
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3.1.4 Assessment of causality
One of the more difficult tasks in epidemiological research is to assess whether
associations between exposure and disease derived from observational epidemiological
studies are of a causal nature or not. It has been underlined above that observational
epidemiological studies are subject to the influence of factors over which the
investigators most often do not have full control, and that findings from these studies are
less reliable than those of studies with an experimental research design. It is therefore
imperative that findings from analytical epidemiological studies are critically scrutinized
before any judgment of causality is made. Furthermore, findings from one single
epidemiological study only exceptionally provide conclusive evidence of a causal
relationship between exposure and disease. Discussions and reasoning concerned with
which criteria to apply for the assessment of causality have been given by several
authors1 2 3.
Bradford Hill2 has listed nine aspects concerned with the association between exposure
and disease which need to be considered. The first of these is the strength of association.
A strongly elevated RR is more likely to reflect a causal association than is a slightly or
moderately increased risk. Consistency of findings across studies conducted with
different methodologies and in different settings, is another aspect. A third characteristic
is specificity, that the exposure causes a particular disease. An important condition is the
sequence of events: the potentially causative factor must precede the effect (disease).
The dose-response relationship, or biological gradient, is another aspect.
                                                                
1 Evans AS, 1978
2 Hill AB, 1965
3 Lilienfeld et al, 1980
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Biological plausibility is an aspect which is important, but depends on the biological
knowledge of the day. The association should be consistent with what is generally
known about the occurrence of the disease, its natural history and pathophysiology, and
should not conflict with its knowledge. The causal interpretation of an association is
furthered if there is experimental evidence in support of it, for example if elimination of
exposure reduces the incidence of the disease. The ninths aspect is analogy. For
example, if a virus is shown to be oncogenic in animal studies, we are more prone to
accept that the human papilloma virus may be the cause of cervical cancer in humans. In
this essay on association and causation, Bradford Hill notes that none of his nine
viewpoints can bring indisputable evidence for or against the cause-and-effect
hypothesis and none can be required as a sine qua non (equivalent).
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3.2 Work Plan
Figure 3.1: Stages of research protocol
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During the first stage, subjects were selected from ‘Ramat Marpe’, an Imaging Institute,
which serves a large number of private patients and those of one of the largest sick funds
in Israel, after having undergone US examination (after a fast of at least eight hours). 61
cases and 51 controls came to the Imaging Institute for abdominal pain, and 19 cases and
20 controls came for a general checkup. Other reasons for US examination included
urinary tract infection (UTI), chronic liver or kidney problems, or general ill-feeling.
There were no significant differences in the reasons for undergoing US between the
subjects in both groups. All potential cases, as well as controls had to fit clearly
specified inclusion and exclusion criteria.
Stage two of the study comprised an interview where all the participants were
questioned primarily about their usual food intake and eating habits using a FFQ. This
was designed to obtain qualitative, descriptive data on usual intakes of foods or classes
of foods over a long time period. The FFQ also contained general questions on other
factors which might play a role in the etiology of cholesterol GS disease (cholelithiasis),
such as weight and height, physical fitness, concomitant diseases and use of prescribed
drugs in the past 15-20 years, education, occupation and workplaces in the last 20 years,
family history, and serum cholesterol and TG levels.
The third stage consisted of data collection, analysis of existing data using a validated
computer software, statistical calculations and drawing of conclusions.
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3.3 Study Subjects
The study was conducted in Tel Aviv and its vicinity. 278 subjects were approached,
after they had undergone US examination in the imaging institute ‘Ramat Marpe’. 31
subjects could not be enrolled as they did not fit one or more of the inclusion or
exclusion criteria. 24 of the approached subjects (11 cases and 13 controls) refused to
participate, due to various reasons, such as no time, too personal questions, no interest at
all. At the end 11 controls remained that did not have a case to which to compare. We
hope in the future to be able to approach them again for additional research. The final
number of participants was 206 subjects, of which 103 were recently diagnosed,
asymptomatic GS patients and 103 were controls, matched to the cases by gender, age
and region of birth. Altogether 75 female pairs and 28 male pairs were included into the
final analysis.
3.3.1 Inclusion and Exclusion Criteria (determined prior to study start)
I. Cases, i.e. recently diagnosed, asymptomatic GS patients
Inclusion Criteria:
· Existence of GSs proven by US examination
· 18-75 years of age at time of interview
· Females and Males
· Existence of asymptomatic(‘silent’) GSs, i.e. no symptoms whatsoever
· Existence of GSs is known for a period less than three months prior to
interview
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Exclusion Criteria:
Anybody suffering from the following diseases:
· DM
· Inflammatory Bowel Disease (Crohn’s disease and Ulcerative Colitis)
· Renal failure
· HD
· Cancer
· Any other chronic, debilitating disease
II. Controls, i.e. matched to the cases by gender, age and region of birth. The latter was
divided into the following groups:
A. North Africa and Western Asia (Iraq, Iran, Syria, Yemen, etc.)
B. Europe and USA
C. Balkans (Bulgaria, Greece, Turkey, etc.)
D. Israel
Inclusion Criteria:
· Absence of GSs proven by US examination
· 18-75 years of age at time of interview
· Females and males
Exclusion Criteria:
Same as for cases
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3.4. Questionnaire (see appendix 10.1)
All the participants of the study underwent a standardized interview lasting
approximately 1½ hours using a pre-coded questionnaire on diet and lifestyle habits.
They were interviewed by the PhD candidate herself (EK), who is a certified nutritionist
and has undergone special training to learn the interview technique. The interviews took
place primarily at the participants’ home (figure 2), its advantage being that the
dimensions of certain dishes, utensils and foods could be measured and portion size
could therefore be estimated more accurately. The rest were interviewed either at the
imaging institute and some at their workplaces. Those interviewed in the clinic were
interviewed immediately after their US examination. All other subjects were interviewed
within four weeks of their US examination.
Figure 3.2: Places subjects were interviewed
Work 
16%
Clinic
31%
Home
53%
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The questionnaire was made up of the following parts:
· Questions on the medical history of the participant, of family members, medication
intake, and other therapies.
· Questions on demographics, such as gender, age, country of birth, education,
profession, marital status.
· Questions on anthropometric data, such as weight, height, calculation of BMI, and
on physical activity, smoking habits.
· Questions for women only, such as hormone intake, age at first pregnancy, age at
first menstruation and / or menopause, number of pregnancies, number of births.
· Questions on food intake and dietary habits, which made up the main part of the
interview.
The questionnaire on dietary intake:
The questionnaire used was a FFQ. The questionnaire was made up of approximately
175 food items (foods not mentioned on the list, but consumed by the participant, were
added), including typical ethnic dishes which are consumed by groups of different
origins of the Israeli population, soft drinks and alcoholic beverages. The questionnaire
was designed so as to evaluate current and long-term dietary habits.
Concerning the food items, each participant was asked to describe:
A. The frequency of consumption according to daily, weekly or monthly intake.
B. The number of portions consumed on every occasion.
C. The portion size which was measured by standard sizes of packaging, or according
to specific sizes which were shown on colored pictures of foods in their actual size.
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The interviewee was additionally questioned as to each single item, whether there were
changes in the dietary habits prior to the knowledge of the disease (controls: prior to the
interview). Furthermore the interviewee was asked to reconstruct as far back as possible,
at least ten years, whether there have been any changes in the dietary habits. If there
were changes, the previous dietary habits were documented in the same manner as
described above. As a result we received information on the eating habits in two
different time frames:
· Eating habits of the past
· Current (very recent) eating habits
The gathering of the information on eating habits for both time frames gave me the
opportunity to determine whether past as well as current dietary habits may play a role
in the etiology of cholesterol GS disease. GSs may take years to develop and the factors
in the diet may take many years to produce their effect. This type of questionnaire and
its effect on study results was discussed previously1.
3.4.1 Portion sizes
Natural units, standard units of packaging, and individual portion sizes as determined by
life-size color photographs, were used to quantify portion size. In cases where the
interview took place at home, participants were asked to show typical dishes, and/or the
item itself for accurate recording.
                                                                
1 Lubin et al, 1998
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3.4.2 Frequency of consumption
The adult population is known to change nutritional habits for health and other reasons.
Therefore, for each item, the interviewer (EK) asked whether any changes had occurred
in consumption habits during the last 10 years. If yes, first the more recent and then the
pre-change habits (‘past’ consumption) were recorded in an identical set of columns
including the same questions as for the more recent period (frequency, number of
portions and portion size) as well as the number of years since the change occurred. For
items in which no change was reported, present habits were equivalent to past habits and
used for the analysis. This method allowed evaluation of pre-change habits (past
consumption), which represent long-term life habits. Because a longer period of
exposure to a nutritional factor is expected to be of greater biological importance, the
data in the present study are given for past consumption (³2 years), providing
information more relevant to cholesterol GS etiology.
The reliability of the dietary history questionnaire with respect to reporting past habits
has been evaluated in previous epidemiological studies on nutrition and cancer1 2 3 4. In
the present study EK re-interviewed a random sample of 10 cases and controls after one
year (± 1 month) at the same setting. The reproducibility of the habitual (long-term
consumption) frequency was 83%, for the number of portions 89%, and for the portion
sizes 90%.
                                                                
1 Lubin et al, 1998
2 Lubin et al, 1997
3 Lubin et al, 1986
4 Modan et al, 1974 and 1975
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3.4.3 Food item-and-frequency coding
In order to make the analysis easier the food items were encoded in such a manner that
food items of the same family, such as milk products would always start with the same
number. The frequency of consumption was encoded too, so that for example, monthly
consumption was labeled with an ‘A’, bi-monthly consumption was labeled ‘B’, etc.
Regarding weekly consumption, the number of days were directly copied (see appendix
10.1). Certain food items are only available during certain time periods and this
seasonality was accounted for (see p.62).
3.5 Food Supplement-and Medication Intake
Subjects were asked to recall whether they are taking, or have taken any food
supplements, such as multivitamins, minerals in the past, and for how long. Any
information on regular medication intake, its indication and period of intake was
collected and recorded.
3.6 Parity and Hormonal Intake (females only)
From the literature it is known that women in general, suffer more from cholelithiasis
than men1 2 3, therefore all female participants were asked several questions concerning
menarche, menopause, number of pregnancies, number of births, use of hormones, so as
to give us a clue to potential mechanisms.
                                                                
1 Balzer et al, 1986
2 Barbara et al, 1987
3 Attili et al, 1995
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3.7 Physical Activity
The questionnaire was designed so as to estimate the average level of physical activity
of the study participants. It included information about weekly to monthly hours spent
on different activities at work, at home, and at leisure. The description of activity
categories in the questionnaire were similar to those described in the recommended
dietary allowances (RDA) of the National Research Council (NRC)1 for hours spent
resting and sitting, and hours spent performing very light, light, moderate and heavy
physical activity. The category of very heavy (exceptional) activity was not applicable to
our more sedentary population.
Physical activity was categorized into three levels of intensity (low, medium, high)
according to the distribution of an individual ‘activity score’, consisting of the number
of weekly hours spent in activities of moderate to heavy intensity plus one-half the hours
of light-intensity activity. The OR was determined comparing the upper to the lower
tertile. This method was found previously to be effective in other population studies2 3.
                                                                
1 NRC, 1989
2 Modan et al, 1986
3 Lubin et al, 1997
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3.8 Education, Profession and Work Places
In order to determine the socio-economic background of the participants, years of
education, as well as the profession of each participant was recorded. The participants
were also asked to record their current occupation, as well as all workplaces in the past,
with special attention to chemical exposure at work, and or at home (eg. cleaning
material).
3.9 Smoking Habits
Lifetime tobacco smoking habits were ascertained by asking the participants whether
they were smoking or not, smokers were asked about their age when they started and/or
stoped smoking, number of cigarettes smoked per day at present and/or in the past.
To assess tobacco use, a score based on the mean number of cigarettes smoked per day
times 365, times the number of years of smoking, was used for present and past
smokers. Two levels of smoking were determined according to the median score, and
ORs were derived using ‘never smoked’ as a reference category.
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3.10 Weight, Height and Body Mass Index (BMI)
For the weight history, current weight was measured, without shoes and jackets, using
the same scale for all participants, and all subjects had to report their weight during most
of their adult life and their weight at 18 years of age. Those who could not remember,
were asked to at least determine whether weight was less or more than at the time of
interview.
Height, without shoes, was measured with the same instrument for all participants. The
BMI was calculated, using the formula weight/(height)2, kg/m2. Weight change from age
18 years to adulthood was calculated from the difference between both values.
3.11 Family Disease
All study subjects were questioned about disease in the family, specifically for first and
second degree relatives. Disease histories were recorded for parents, sisters and brothers,
aunts and uncles, and grandparents. Those who were not sure completed the information
over the phone.
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3.12 Serum Lipids
Cases and controls were asked whether they had any blood tests taken not longer than
three months prior to the interview. Those who had (n=178), agreed to forward their TG
and cholesterol levels to us. 28 of the subjects had no recent blood tests taken, but
agreed to have them following the interview. Therefore we had complete laboratory data
on serum lipids for all subjects.
At this point it is worth mentioning that all subjects were recruited from the same
Imaging Institute, and were all insured at the same sick fund, which uses the same
laboratory for the Tel Aviv area.
3.13 Data Analysis and Statistical Calculations
The statistical analyses were made using SAS (version 6.12) software on a UNIX
platform.
3.13.1 Study population size
The sample size calculation was performed for one risk factor. Since the study was of a
matched case-control type, only discordant pairs (i.e. case exposed and control not
exposed or vice versa) take place in the analysis. We assume one third of the general
population to be exposed to the major risk factor (dietary fat) and the standard alpha, a  =
0.05 and beta, b  = 0.80. Since the direction of the influence of the factor is obvious, a
one sided test was done.
Under these assumptions, the required sample size is calculated by a formula similar to
the one used for testing a single binomial proportion1.
                                                                
1 Schlesselman JJ, 1992
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Implementing the formula and assuming the 80% power to be achieved at a relative risk
(OR) of 2 we finally arrive at: 107 pairs , i.e. sample size of 214.
OR (controls) = p0 / q0; where q0 = 1-p0
OR (cases) = p1 / q1; where q1 = 1-p1
McNemar’s test: m = 
2
2
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3.13.2 Energy and nutrient intake
Reported food consumption (monthly and weekly) was converted into average daily
amounts consumed. A comprehensive computer program was developed at the
Department of Clinical Epidemiology, Chaim Sheba Medical Center. The program
enabled quantitative analysis of the dietary profile at any level desired, including foods,
food groups, and food components. First, the program converted all frequencies into
weekly frequency and all portion sizes to total weekly amounts for both periods, the past
and present, and then to mean daily consumption. Length of season was taken into
account when calculating average weekly consumption of fruits and vegetables that are
consumed in season.
This was done using the formula below:
No of calories kcal x grams x no of portions x no of times per week        no of mths
consumed per day =
of the food item 7 (days)        12 (mths)
A similar formula was used in order to calculate the exact amounts of the macronutrients
consumed daily (fat, proteins, carbohydrates) as well as the micronutrients, such as the
intake of vitamins and minerals of each individual.
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The food analysis software was based on Israeli food tables1, where the dietary fibre
analysis was taken from tables of ‘Mc Cance and Widdowson’s Compositions of food’2.
The PL content of foods was specially analyzed in our labs and compared to those of
Souci et al3 and added to the software.
Table 3.3: List of nutrients analyzed
NUTRIENTS
è Carotin è Phosphatidylcholine
è Calcium è Phosphatidylethanolamine
è Carbohydrates è Phosphatidylinositol
è Cholesterol è Phosphatidylserine
è Dietary fiber è Phospholipids, total
è Energy è Potassium
è Fat, total è Proteins, total
è Fat, animal è Proteins, animal
è Fat, vegetables è Proteins, vegetables
è Fat, polyunsaturated è Retinol
è Fat, saturated è Sphingomyelin
è Fat, monounsaturated è Starch
è Magnesium è Sugar
è Nitrogen è Vitamin C
è Nitrate è Vitamin E
è Nitrit è Zinc
Table 3.4: List of foods and food groups analyzed
FOODS / FOOD GROUPS
è Alcoholic beverages è Milk products
è Beef è Oils, animal
è Bread and Cereals è Oils, vegetables
è Chicken è Olives
è Coffee & Tea è Pulses
è Dried Fruits è Seeds
è Eggs è Soft Drinks
è Ethnic Dishes è Sweets
è Fish è Vegetables
è Fruits è Water
                                                                
1 Guggenheim et al, 1991
2 Paul et al, 1978
3 Souci et al, 1989
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Analysis of the incidence tables
The incidence tables of the type 2x2 have been calculated for cases matched by two
dichotomous variables (e.g. gender and disease). Using those tables we tried to ascertain
the potential dependency of those two variables using the method described by Fisher1.
Concerning the 2xC tables (C>2) is to check whether a linear relation exists between an
ordinal variable and another. The test is therefore the Mantel Haenszel test2.
On the basis of the linear distribution of intake by the total population (cases and
controls), three levels of intake (low, medium, high) were determined.
ORs associated with these tertiles of mean daily consumption of each food item or food
component was calculated by conditional logistic regression analysis 3, adjusting for
energy intake. The lowest level was used as a reference category. Corresponding, 95%
confidence intervals (CIs) were determined, and the significance for linear trend was
calculated1. ORs presented in the following chapter, will be comparing the upper to the
lower tertile, although figures for medium vs lower levels are available too, which are
important in proving linear association.
3.13.3 Life style parameters
Cutpoints for three levels of physical activity, body weight, weight change, BMI, and
tobacco use were defined as for the other parameters, according to the linear distribution
of values of both cases and controls.
To assess the independent effect of each of the lifestyle parameters studied, adjusting for
all others, a multivariate logistic model was also fitted4.
                                                                
1 Sokal et al, 1981
2 Mantel et al, 1959
3 Breslow et al, 1980
4 Schlesselman JJ, 1992
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4. RESULTS
4.1 Study Subjects (demographic background)
Table 4.1: No. of subjects in each of the subgroups, which were analyzed
Cases Controls
All 103 103
Females 75 75
Males 28 28
< 45 51 51
> 45 52 52
Israel born 64 64
4.1.1 Age
Initially the age span for inclusion was set from 18-75. Nevertheless, as can be seen in
table 4.2, the youngest subject in the trial was 24 years of age at the time of the
interview, and the oldest was 73.
Table 4.2: Age (years) distribution among study subjects
CASES CONTROLS
Females Males Total
Group
Females Males Total
Group
ALL
N 75 28 103 75 28 103 206
MEAN 45 48 45.8 44.7 46.1 45.1 45.4
STD 13.7 13.9 13.7 13.1 13.4 13.1 13.4
Min 25 27 25 24 27 24 24
Max 69 73 73 73 70 73 73
Table 4.3: Division of subjects into two age groups
Cases Controls
N % N %
< 45 years 51 48.5 51 51.5
> 45 years 52 51.5 52 48.5
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4.1.2 Ethnicity
The study subjects were also matched according to region of birth, so as to ensure
appropriate comparison between cases and controls. Israel is known for the fact that the
population is diverse, as Jews have immigrated from many parts in the world. All study
subjects were subdivided for analysis into 4 groups (see table 4.4). Subjects who were
born in Israel were matched according to their mother’s region of birth. Analysis in this
paper was made only for the latter group, which made up 64 of the 103 pairs (figure
4.1). The three other groups were too small to derive any meaningful conclusions.
Table 4.4: Regions of birth: Division
Area Codes (Place of birth):
Western Europe, North America, South Africa, Australia, New Zealand: 01
Eastern Europe: 02
North Africa, Asia: 03
Israel: 04
Figure 4.1: Participants’ place of birth
7%
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Western Europe
Eastern Europe
North Africa-Asia
Israel
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4.1.3 Family status
All subjects were questioned about their current family status. We found that
significantly more cases were married than their controls in this study (figure 4.2).
Figure 4.2: Distribution of family status
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4.1.4 Religious dietary laws
Religion in the context of this study was used solely to differentiate those subjects that
eat kosher food only from those who do not. In terms of dietary habits this means that
subjects do not consume pork, certain fish and seafood, while meat and milk products
are not consumed at the same time. The distribution among cases and controls was
similar and almost homogenous (figure 4.3).
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Figure 4.3: Religious habits of study subjects
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4.1.5 Education and profession
Regarding the study subjects’ formal education, the mean number of study years was
almost identical for cases and controls, 14.41 & 14.72 respectively. The distribution
among cases and controls was very similar (figure 4.4).
Figure 4.4: Formal education
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Additionally the participants provided information about their professions and their
current and previous occupations. It was observed that the distribution of professions
(figure 4.5), as well as places of work were similar in both study groups (figures 4.6 &
4.7).
Figure 4.5: Profession distribution of study subjects
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Though the control group included significantly more subjects who were students, or
working in a medical institution, and/or working in a bank, the numbers of people were
only a fraction of the entire study population, and therefore no relationship to GS
development has been suggested.
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Figure 4.6: Cases’ places of work
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Figure 4.7: Controls’ places of work
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Controls were significantly more frequently exposed to some sort of chemical, be it
during work and/or at leisure time (figure 4.8). Here again the number of those exposed
to particular chemicals was too small in order to allow any conclusions. The
specification of the chemicals is given below (table 4.5).
Figure 4.8: Exposure to chemicals at work and at leisure
0
20
40
60
80
100
120
140
YES NO
CASES
CONTROLS
*
*p=0.017
Table 4.5: Exposure to chemicals
No. of subjects exposedChemical
Cases Controls
Cleaning material 4 8
Lead 1 1
Pesticides 0 0
Organic solvents 3 5
Radiation 2 10
Colour 0 2
Photo developing material 3 5
Chemicals, unspecified 2 3
Other, unspecified 3 4
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4.2 Dietary Habits
More cases than controls in the present study had never changed their dietary habits for
various reasons. The difference, though, was not significant (p=0.062).
Figure 4.9: Changes in dietary habits
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The most important reasons for change in dietary habits are mentioned in the following
paragraph. The results show that most subjects changed their eating habits only for short
periods in order to loose weight. Others changed their habits completely to try and live a
healthier life, some of them with the primary aim of loosing weight. Immigration was
the third most important reason for a change in eating habits.
Most subjects changed their habits by reducing their total energy intake. More cases
lowered their energy consumption than controls, though the difference was not
significant (p=0.068). Nevertheless, more cases reduced the intake of fat than their
controls (p=0.051). The third biggest change in habits was the reduction of meat
consumption, which was similar between cases and controls.
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No differences between cases and controls were found regarding the speed of food
consumption (figure 4.10).
Figure 4.10: Speed of food consumption
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4.3. Nutrient Intake
Nutrient and food intake follows on the coming pages and is presented for five groups:
· All subjects
· Females only (females tend to have a higher prevalence it was interesting to
determine their risk and protective factors, and the number of male pairs was too
small to draw any conclusions)
· Two age groups, above and below age 45 (in the past people above age 40 had a
significantly higher prevalence, though these observations seem to diminish, it was
interesting to see whether there were marked differences)
· Israeli-born subjects, as they made up the majority of studied subjects.
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4.3.1 Total energy-and fat intake
Total energy intake was shown in females to be a risk factor (figure 4.11). With regard
to fat we examined total fat intake as well as polyunsaturated, monounsaturated,
saturated fat intake, cholesterol intake, fat of animal origin and of vegetable origin. We
could observe that total fat, and especially fat originating from animals was a risk factor
in all subjects. Animal fat presented itself as a risk factor especially in the older
population and those born in Israel with a more than six-fold risk, but the younger
subjects also showed a four times higher risk to disease from GSs. The results for sub-
groups that emerged (non-significant results) are presented in table 4.7.
Figure 4.11: Risk factors: Energy & fats
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We divided food and nutrient intake into three levels. This is shown on table 4.6 and
tables that will follow as percentiles, 33% and below (low), 50% (medium), and 66%
and above (high), respectively. With regard to energy intake that means that females
who ate a diet with an energy content of =1909.48 kcal daily have a 2.9 greater risk of
developing GSs than females consuming =1436.82 kcal daily.
Table 4.6: ORs, p-value, mean intake & percentiles of significant results:
Energy and fats
Item Group Odds
Ratio
p-value Mean 33.3 % 50 % 66.6 %
Energy [kcal] Females 2.895 0.023 1790.51 1436.82 1678.51 1909.48
Total fat [g] All 4.166 0.038 73.12 55.20 64.63 79.48
All 4.555 0.001 33.14 23.64 28.51 34.58
> 45 yrs 6.667 0.016 33.34 23.19 26.87 33.36
< 45 yrs 3.795 0.034 32.94 24.32 28.57 34.89
Animal fat
[g]
Israel-born 6.555 0.004 32.49 23.50 26.39 34.54
Table 4.7: ORs, p-value, mean intake & percentiles of non-significant results:
Energy and fats
Item Group Odds
Ratio
p-value Mean 33.3 % 50 % 66.6 %
All 1.862 0.093 1881.11 1493.29 1779.12 1962.33
> 45 yrs 1.546 0.388 1811.66 1445.57 1700.15 1908.20
< 45 yrs 1.937 0.210 1951.92 1538.39 1851.95 2058.18
Energy [kcal]
Israel-born 2.035 0.113 1955.98 1538.39 1851.68 2039.41
Females 0.230 0.239 69.12 52.91 61.66 75.17
> 45 yrs 5.120 0.109 70.27 53.72 62.15 73.02
< 45 yrs 1.568 0.629 76.03 56.18 67.69 82.76
Total fat [g]
Israel-born 2.417 0.239 76.28 56.18 67.19 83.32
Animal fat [g] Females 2.591 0.071 31.39 23.19 25.67 31.35
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4.3.2 Proteins
The consumption of proteins with regard to risk of GS disease was probably the biggest
surprise in our analyses. Never before was such a strong co-relation observed. Total
protein intake resulted in an over ten-fold risk elevation (figure 4.12) when consuming
=80.20 grams daily as opposed to =62.69 grams per day (table 4.8). This trend was
found in the young, old, and Israel-born subjects. Consumption of protein of animal
origin was also associated with GS, though the association was less strong, except in the
young subjects where the risk was 9.9 times higher. Nevertheless the trend could be
observed as a 4-5 times fold elevated risk in all other subgroups analyzed.
Figure 4.12: Risk factor: Proteins
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Table 4.8: ORs, p-value, mean intake & percentiles of significant results: Proteins
Item Group Odds
Ratio
p-
value
Mean 33.3 % 50 % 66.6 %
All 11.440 0.0001 75.37 62.69 71.59 80.82
> 45 yrs 8.207 0.025 73.58 62.07 69.60 79.66
< 45 yrs 4.700 0.040 77.20 62.69 73.64 83.33
Total Protein [g]
Israel-born 7.187 0.015 77.27 63.92 73.64 83.95
All 4.800 0.0001 41.55 31.67 37.87 46.67
Females 5.318 0.002 72.21 30.57 36.14 45.00
> 45 yrs 9.931 0.002 41.98 32.52 38.81 47.71
< 45 yrs 5.142 0.007 41.11 30.46 36.08 46.31
Animal protein
[g]
Israel-born 4.124 0.006 41.39 31.81 39.87 46.34
Table 4.9: ORs, p-value, mean intake & percentiles of non-significant results:
Proteins
Item Group Odds
Ratio
p-
value
Mean 33.3 % 50 % 66.6 %
Total Protein [g] Females 3.664 0.059 72.21 60.85 67.84 77.81
All 0.908 0.822 24.91 19.18 22.61 27.00
Females 0.789 0.631 24.05 18.55 21.31 25.85
> 45 yrs 0.406 0.219 23.39 19.15 20.91 24.60
< 45 yrs 0.975 0.966 26.45 19.18 25.48 29.07
Vegetable Protein
[g]
Israel-born 1.094 0.880 26.03 19.38 24.33 28.48
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4.3.3 Carbohydrates
Dietary fiber was shown to be protective in all subjects, and in subjects born in Israel
(figure 4.13). In detail, a consumption =20.95 grams per day, compared to =15.21 grams
per day reduces the risk of developing GSs by almost four (OR: 0.28) in all subjects.
The same association was observed with starch in the older subjects studied, where a
consumption =133.96 grams per day, compared to =96.10 grams per day reduces the risk
of developing GSs by nearly five (OR: 0.21) (table 4.10).
Figure 4.13: Risk factor: Complex carbohydrates
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Table 4.10: ORs, p-value, mean intake & percentiles of significant results:
Dietary fiber and starch
Item Group Odds
Ratio
p-
value
Mean 33.3 % 50 % 66.6 %
All 0.279 0.009 19.99 15.21 17.89 20.95Dietary fiber[g]
Israel-born 0.239 0.018 20.90 15.84 18.69 22.26
Starch [g] > 45 yrs 0.214 0.030 122.94 96.10 114.63 133.96
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Table 4.11: ORs, p-value, mean intake & percentiles of non-significant results:
Dietary fiber and starch
Item Group Odds
Ratio
p-
value
Mean 33.3 % 50 % 66.6 %
Females 0.343 0.056 19.99 15.21 17.89 20.95
> 45 yrs 0.304 0.054 20.90 15.84 18.69 22.26
Dietary fiber[g]
< 45 yrs 0.241 0.067 19.39 14.35 16.78 19.72
All 1.007 0.986 122.94 96.10 114.63 133.96
Females 1.211 0.702 127.04 97.23 119.24 145.67
< 45 yrs 1.190 0.806 146.98 114.35 142.23 164.69
Starch [g]
Israel-born 1.112 0.860 142.07 107.29 136.14 159.24
4.3.4 Micronutrients
PS turned out to raise the risk of GS development. Contrary to this, zinc was shown to
be protective.
Figure 4.14: Risk factor: Micronutrients
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Table 4.12: ORs, p-value, mean intake & percentiles of significant results: PS and
zinc
Item Group Odds
Ratio
p-value Mean 33.3 % 50 % 66.6 %
All 2.506 0.016 34.71 15.49 27.23 37.39
Females 3.540 0.018 32.80 14.63 24.94 33.96
Phosphatidyl
serine [mg]
< 45 yrs 4.297 0.020 32.33 13.16 19.98 35.47
Zinc [mg] Israel-born 0.238 0.028 102.10 70.77 84.58 101.70
Table 4.13: ORs, p-value, mean intake & percentiles of non-significant results: PS
and zinc
Item Group Odds
Ratio
p-value Mean 33.3 % 50 % 66.6 %
> 45 yrs 1.794 0.243 37.04 18.17 28.90 37.85Phosphatidyl
serine [mg] Israel-born 1.989 0.130 33.03 13.84 22.96 33.11
All 0.391 0.055 93.24 68.09 79.77 95.82
Females 0.473 0.223 89.73 66.38 77.26 91.05
< 45 yrs 0.712 0.635 105.30 69.39 85.53 104.43
Zinc
[mg]
> 45 yrs 0.391 0.157 81.40 66.48 77.64 88.14
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4.4 Specific Foods and Beverages
Alcohol intake as well as the consumption of soft drinks were inversely associated with
the risk of GSs. The same association was observed with the consumption of dried fruits
and soft drinks.
In contrast beef, chicken, fish and fruits showed a positive association to GS
development. Chicken was associated with an increased risk among all study subjects,
whereas the relation to beef was observed only in the younger subjects. Fish was related
to an increased risk in the older subjects. Olive intake was associated with an increased
risk in Israel-born subjects (figure 4.15).
Figure 4.15: Risk factor: Specific foods
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Table 4.14: ORs, p-value, mean intake & percentiles of significant results: Foods
Item Group Odds
Ratio
p-value Mean 33.3 % 50 % 66.6 %
Alcohol [ml] All 0.461 0.039 2.35 0.00 0.67 1.71
Beef [g] < 45 yrs 3.584 0.029 18.55 3.93 10.35 20.00
All 3.982 0.0001 68.39 45.43 59.89 81.43
Females 4.609 0.001 64.31 42.72 55.69 71.43
< 45 yrs 5.481 0.007 68.48 45.71 59.54 72.27
> 45 yrs 4.146 0.009 68.30 43.60 60.80 82.06
Chicken [g]
Israel-born 3.948 0.006 70.36 45.43 60.80 88.09
Dried fruits
[piece]
< 45 yrs 0.294 0.022 8.37 0.00 0.00 2.30
Fish [g] > 45 yrs 6.573 0.002 24.16 10.82 20.01 28.15
Olives
[piece]
Israel-born 3.553 0.031 3.65 0.86 1.43 2.86
Soft Drinks
[ml]
Israel-born 0.271 0.016 975.40 640.00 864.76 1154.29
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Table 4.15: ORs, p-value, mean intake & percentiles of non-significant results:
Foods
Item Group Odds
Ratio
p-value Mean 33.3 % 50 % 66.6 %
Females 0.489 0.074 1.48 0.00 0.10 1.18
< 45 yrs 0.476 0.155 2.17 0.00 0.67 1.71
> 45 yrs 0.497 0.190 2.53 0.00 0.61 1.71
Alcohol [ml]
Israel-born 0.566 0.187 2.15 0.00 0.54 1.71
All 1.306 0.470 16.26 2.86 7.91 17.14
Females 1.163 0.731 12.82 1.97 5.81 12.46
> 45 yrs 0.783 0.674 14.00 0.82 5.25 14.29
Beef [g]
Israel-born 2.042 0.125 16.24 2.86 7.87 17.47
All 0.568 0.112 9.05 0.00 0.00 4.59
Females 0.551 0.137 9.87 0.00 0.66 4.59
> 45 yrs 1.186 0.747 9.73 0.00 1.64 4.92
Dried fruits
[piece]
Israel-born 0.751 0.507 9.50 0.00 0.66 5.71
All 1.822 0.08 22.16 9.51 16.72 26.07
Females 1.771 0.170 21.42 10.00 16.89 25.36
< 45 yrs 0.674 0.469 20.12 5.57 12.59 24.27
Fish [g]
Israel-born 1.935 0.152 19.53 7.70 13.85 23.28
All 1.494 0.328 3.36 0.79 1.43 2.86
Females 0.529 0.454 2.99 0.66 1.43 2.86
< 45 yrs 2.000 0.236 3.47 0.79 1.43 2.86
Olives
[piece]
> 45 yrs 1.208 0.751 3.26 0.66 1.57 2.86
All 0.484 0.051 1008.54 670.48 906.67 1226.67
Females 0.512 0.128 980.69 640.00 880.00 1177.14
< 45 yrs 0.334 0.052 1053.58 708.57 929.52 1241.90
Soft drinks
[ml]
> 45 yrs 0.641 0.384 964.35 640.00 851.43 1120.00
84
4.5 Nutrients and Foods after Multivariate Analysis
When we realized that proteins  had such a strong association with the disease under
investigation, an additional analysis was performed, when all nutrients were adjusted to
energy and proteins. Chicken persisted as a major risk factor. Beef remained a risk factor
in the young subjects and so did fish in the older subjects.
Figure 4.16: Risk factors when adjusted to energy and proteins
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We also did additional analysis, when all nutrients were adjusted to energy and fat. In
figure 4.17 can be seen that again that risk factors remained as they were in the initial
analysis which was adjusted to total energy only.
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Figure 4.17: Risk factors when adjusted to energy and fat
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As we found that significantly more cases were married, we wanted to determine which
factors might play a role, as the fact of being married could obviously not be the reason
for GS development. In figure 4.18 we can see the results for those matched pairs where
both, case and control, were married.
Figure 4.18: Risk factors for married individuals only (n=61 pairs)
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BMI turned out to be a risk factor (see section 4.6), so we did sub-analysis to control for
relative weight. As can be seen on the figure below the risk factors remained almost
identical (beef, olives and total fat disappeared as risk factors, and alcohol disappeared
as a protective factor) as were observed without controlling for relative weight (being a
risk factor in itself).
Figure 4.19: Risk factors when adjusted to energy and BMI
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4.6 Anthropometric Influences
Weight was shown to be an important risk factors for the development of GSs. The
weight distribution among the study subjects is shown in table 4.16. Nevertheless, I
chose to show the results for BMI, as it is well known that weight in relation to height is
a more exact way of presenting weight-related risk factors. In all subjects, and in all
subgroups analyzed, BMI turned out an important risk factor (figure 4.20). The exact
data can be seen in table 4.17.
Table 4.16: Weight [kg] distribution among study subjects
CASES CONTROLS
Females Males Total
Group
Females Males Total
Group
ALL
N 75 28 103 75 28 103 206
MEAN 69.2 80.3 72.2 62.2 79.0 66.7 69.5
STD 15.2 14.3 15.7 9.7 17.4 14.2 15.2
Min 47.0 54.0 47.0 45.0 56.0 45.0 45.0
Max 140.0 120.0 140 86.0 137.0 137.0 140.0
Figure 4.20: Risk factor: Body Mass Index
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Table 4.17: ORs, p-value, mean intake & percentiles of significant results:
BMI
Item Group OR p-value Mean 33.3 % 50 % 66.6 %
All 4.492 0.0001 24.64 22.23 24.10 25.70
Females 5.601 0.001 24.46 22.04 23.55 25.33
> 45 yrs 4.079 0.018 24.99 22.48 24.37 26.31
< 45 yrs 4.035 0.023 24.26 21.74 23.44 25.42
Current
BMI
[kg/m2]
Israel-born 5.521 0.004 24.49 22.04 23.32 25.00
Females 3.850 0.007 17.70 18.75 19.56 20.93
< 45 yrs 3.364 0.029 17.16 18.75 20.17 21.36
BMI at
age 18
[kg/m2] Israel-born 4.103 0.006 17.24 18.75 20.02 20.96
4.7 Medication-and Supplement Intake
The disease status as well as medications and the intake of food supplement were
ascertained by asking the subject whether medication was ever taken for a period longer
than three months. There were no significant differences between cases and controls
regarding both, medication and supplements (figures 4.21 & 4.22). This might be due to
the fact that only a small number of subjects had taken any medication or food
supplements at the time of interview or in the past. Therefore no conclusions could be
drawn.
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Figure 4.21: Intake of food supplement
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Figure 4.22: Chronic use of medications
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4.8 Family History
The most striking difference in family history was the fact that in all subjects and all
subgroups analyzed the number of other family members suffering from GSs, was
significantly higher in the families of the cases than in those of the controls. This effect
is presented in two ways. Figure 4.23 shows results when all family members are
counted for all diseases. As sizes of families differ among the subjects, especially in
Israel there is often a difference in the number of children per family between families of
Ashkenazi (East-European background) and Sephardi heritage (Sephardi families tend to
have more children), the results of family history were mainly presented when only one
family member was counted per disease (figures 4.24 - 4.29). The way of presentation
had no significant effect on the results.
Figure 4.23: Cumulative family disease
0
20
40
60
80
100
120
140
160
180
N
o.
 o
f s
ub
je
ct
s'
 fa
m
ily
 
m
em
be
rs
HD DM GS * HT HC CA Hol
Medical Conditions
Cases
Controls
* Significant difference (p<0.001)
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Figure 4.24: Family diseases (all) when only one person is reported in the family
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Figure 4.25: Mothers’ medical history
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* Significant difference (p<0.001)
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Figure 4.26: Fathers’ medical history
0
5
10
15
20
25
30
35
N
o.
 o
f s
ub
je
ct
s'
 fa
m
ily
 m
em
be
rs
HD DM GS * HT HC CA
Medical Conditions
Cases
Controls
* Significant difference (p=0.033)
Figure 4.27: Family medical history: Sisters & Brothers
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HD – Heart Disease; DM – Diabetes Mellitus; GS – Gallstones; HT – Hypertension; HC
– Hypercholesteremia; CA – Cancer; Hol – died during the Holocaust
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Figure 4.28: Family medical history: Maternal side of the family (uncles & aunts,
grandparents)
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Figure 4.29: Family medical history: Paternal side of the family (uncles & aunts,
grandparents)
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* Significant difference (p=0.014)
HD – Heart Disease; DM – Diabetes Mellitus; GS – Gallstones; HT – Hypertension; HC
– Hypercholesteremia; CA – Cancer; Hol – died during the Holocaust
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Of the first degree family members we found 44 (86%) members with GSs of cases’
families versus 7 of controls’ families. Of the 51 GS-carrying members 33 (75%) were
females. Of the family members of the maternal side, 18 GS carriers (86%) were of
cases’ families and 3 of controls’. In the paternal side we found much lower figures, 7
members of cases’ families had GSs and none of the controls.
4.9 Physical Activity
No significant difference in physical activity was observed between cases and controls
in this study.
4.10 Smoking
At the time of interview only 18 cases and 18 controls reported being smokers. 30 cases
and 32 controls, had smoked in the past. None of our analyses could prove a significant
difference in smoking habits between cases and controls.
4.11 Parity and Hormonal Intake (females only)
There were no significant differences between female cases and controls in either of the
parameters checked, which are shown in figures 4.30 – 4.32. Mean age at menarche,
first pregnancy and menopause were almost identical. The same was true for number of
pregnancies and deliveries. Use of contraception and hormone replacement therapy
(HRT) and breast-feeding was very limited in cases as well as controls. Therefore no
significant differences were observed.
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Figure 4.30: Mean age at menarche, 1st pregnancy and menopause
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Figure 4.31: Number of pregnancies and deliveries
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Figure 4.32: Use of contraceptive pills and/or HRT, and breast-feeding
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4.12 Serum Lipids
The analysis of all subjects showed that a total serum cholesterol of = 224.00 (table
4.18) elevated the risk of GS development by 2.2 (figure 4.33) as compared to subjects
with a figure of = 191.00. The same trend could be observed for those subjects born in
Israel. Regarding serum TGs we could also see that subjects with a TG level = 138.00
had a 2.92 fold elevated risk of developing GSs as compared to those with a level =
95.00. The same trend could be observed in females and Israel born subjects.
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Figure 4.33: Risk factor: Serum lipids
0
4
8
Cholesterol Triglycerides
O
dd
s 
R
at
io All
Females
Israelis
1
Table 4.18: ORs, p-value, mean intake & percentiles of significant results: Serum
lipids
Item Group Odds
Ratio
p-value Mean 33.3 % 50 % 66.6 %
All 2.2 0.042 212.47 191.00 210.00 224.00Total serum
cholesterol
[mg/dl]
Israel-born 3.274 0.030 209.30 186.00 203.50 221.00
All 2.923 0.008 124.82 95.00 106.00 138.00
Females 2.743 0.034 122.33 92.00 106.00 134.00
Serum
triglycerides
[mg/dl] Israel-born 7.811 0.001 119.95 92.00 102.00 130.00
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Table 4.19: ORs, p-value, mean intake & percentiles of non-significant results:
Serum lipids
Item Group Odds
Ratio
p-value Mean 33.3 % 50 % 66.6 %
Females 2.665 0.054 211.23 189.00 203.50 224.00
>45 yrs 2.276 0.172 223.86 206.00 221.00 238.00
Total serum
cholesterol
[mg/dl] <45 yrs 2.808 0.080 200.86 182.00 195.00 210.00
>45 yrs 1.853 0.262 139.41 107.00 127.50 157.00Serum
triglycerides
[mg/dl]
<45 yrs 2.249 0.107 109.94 80.00 93.50 105.00
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5. DISCUSSION
Factors associated with GS formation, diet and non-diet related, have been established in
the past, and were already presented in depth in chapter 2.4. Following is the discussion
of the methodology used in this study and the study results mainly focusing on possible
mechanisms and/or biological plausibility.
5.1 Dietary Assessment Method
Measuring energy and nutrient intake in humans is a difficult task. Even under the best
possible circumstances, a 10 percent error in precision can be expected1. Several
different methods have been utilized to assess the energy intakes of specific populations
including 24-hour recall, food records, diet history and FFQs. Measured against one
another, most of these methods have some degree of validity2. The method of choice
depends on a number of criteria, including purpose of the survey, the sample size, funds
and personnel availability3. In this study the FFQ was chosen as the best choice taking
into account the criteria mentioned above. A 24-hour recall and food record were not
used as the food intake would be limited to a certain day or week, not taking into
account seasonality and the months or years prior to GS diagnosis or interview, for cases
and controls respectively. Diet histories and FFQs require that study subjects recall their
usual dietary intake over a period of time. These methods are employed frequently to
estimate the intake of foods by rank or category according to frequency of consumption
rather than to provide a quantitative measure of actual intake. The use of these
questionnaires is relatively cheap, easy to use and straight forward for analysis.
                                                                
1 Stern et al, 1984
2 Block G, 1982
3 Pekkarinen M, 1970
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The FFQ is comprised of a comprehensive list of specific food items to record intakes
over a pre-specified period (day, week, month, year). The record is obtained by
interview or by self-administered questionnaire.
Pietinen and colleagues1 examined the reproducibility and validity of a self-administered
food use questionnaire with a portion-size picture booklet and a self-administered FFQ,
which was developed for a lung cancer intervention trial on 27,000 Finnish men. The
reproducibility studies of the questionnaires included 121 men and 107 men,
respectively and the validity study included 190 men. The reproducibility was examined
by filling out both questionnaires three times at an interval of three months, the validity
was compared to 12 day food consumption records, which were recorded twice at an
interval of six months. The authors concluded that the food use questionnaire was better
suited for the assessment of an individual’s habitual intake for a variety of nutrients,
whereas the self-administered FFQ was a useful tool for monitoring qualitative changes
in the diet, for example after intervention, as its reproducibility was high.
In that context, Wheeler et al2 conducted a study to examine the influence of three
different FFQs, and the influence of intervals between their completion. They found no
difference between the formats, but observed that the motivation to complete it for the
second time was considerably less after 4-6 weeks than after 3 months. Many other
validity and reproducibility studies have come to a similar conclusion that FFQs can be
used for large populations and gives valid information to estimate nutrient intakes of
individuals3 4.
                                                                
1 Pietinen et al, 1988
2 Wheeler et al, 1994
3 Andersen et al, 1995
4 Shimizu et al, 1999
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The questionnaire can be semi-quantitative (SQFF) when subjects are asked to quantify
usual portion sizes of food items, with or without the use of food models and/ or pictures
of food portions. There are scholars who have suggested that validity and reproducibility
of FFQs need to be assessed for each individual population. Munger et al1 ascertained
the intake of women in Iowa using the SQFF which was previously shown by Willett et
al2 3 in Boston women to be valid and reproducible. They found similar levels of
reproducibility and agreement relative to the mean of the five 24-hour dietary recalls in
Boston women and therefore concluded that the method was accurate enough to classify
individuals by nutrient intake in large epidemiological studies.
The major drawbacks of this method include:
Ø Self-administered FFQ: No control
Ø FFQ Interview: Inter-and intra-observer bias, less precise quantitation of actual
intake
                                                                
1 Munger et al, 1992
2 Willett et al, 1985
3 Willett et al, 1988
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5.2 Diet-Related Factors
5.2.1 BMI and dieting
This study could identify obesity, by means of BMI, as a risk factor, independent of
energy intake. This was observed in quite a large number of studies published earlier1 2 3
4 5 6 7. The positive association of obesity and GS formation has previously been
explained by a hypersecretion of biliary cholesterol, which is more frequently observed
in obese people8 9. Salen and collegues10 observed an elevation of hepatic cholesterol
synthesis in patients with GSs, which has been shown in animal studies to be stimulated
by insulin11. Insulin was observed to be higher in obese subjects and among subjects
with GSs 12 13 14.
We also found a positive association with high BMI at the age of 18 and GS formation.
This was observed earlier by Maclure and his collegues7. Though we found BMI at
present and BMI at age 18 to be positively associated with GS formation, we did not
further examine whether the same subjects that had a high BMI at age 18 were the same
as those with an elevated BMI at the time of interview. Therefore no conclusion can be
drawn with regard to maintenance of a high BMI or whether some of the subjects had
actually lost or gained weight over the course of their life.
                                                                
1 Friedman et al, 1966
2 Kern F Jr, 1983
3 Scragg et al, 1984
4 Diehl et al, 1987
5 Barbara et al, 1987
6 GREPCO, 1988
7 Maclure et al, 1989
8 Bennion et al, 1975
9 Shaffer et al, 1977
10 Salen et al, 1975
11 Nepokroeff et al, 1974
12 Scragg et al, 1984
13 Stout et al, 1978
14 Norton et al, 1968
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Rapid loss of weight as a result of fasting in obese subjects has been established as a
risk factor in itself1. Supersaturation of bile with cholesterol also results from the
reduced output of solubilizing BAs that occurs during fasting2. Though subjects in this
study were questioned about change of dietary habits, including long and/or short term
diets, no significant differences among cases and controls were found.
5.2.2 Energy intake
Total energy intake in this study was shown in females to be a risk factor. This is in line
with a number of other studies discussed earlier. Other studies found that women with
GSs below age 55 ate significantly more3 4 5. Another study found the opposite in
women older than 606. Those observations suggest that other factors might have an
effect in GS development, such as hormonal differences among younger and older
women. These could be due to menopausal or postmenopausal state and/or use of
contraceptives 7 8 9. In this study we did not analyze women separately with regard to
age, as the number of women was only 75, and a sub-analysis would have made the
results inconclusive due to a small number of subjects in each of the subgroups.
                                                                
1 Broomfield et al, 1988
2 Pattinson et al, 1986
3 Sarles et al, 1969
4 Sarles et al, 1978
5 Williams et al, 1980
6 Smith et al, 1979
7 Scragg et al, 1984
8 Royal College of General Practitioners, 1982
9 Boston Collaborative Drug Surveillance Programme, 1973
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5.2.3 Fats and PS
It was observed that total fat and especially fat originating from animals was a risk
factor in all subjects. This is in agreement with many studies discussed previously.
Though animal fat presented itself as a risk factor especially in the older population and
those born in Israel with a more than six-fold risk, in the younger subjects also a four
times higher risk was shown to disease from GSs. The mechanism of fat has in the past
been described as being similar to that of total energy intake and risk of GSs.
The high ORs might be explainable by the fact that foods originating from animal
sources have been found to be potential risk factors in several ‘Western’ diseases and
they therefore just might be high risk factors. It might also be due to a generally high
consumption of animal foods in Israel, or the subject number was too small after all.
PS turned out to raise the risk of GS development.
Halpern and colleagues1 on the other hand showed that the addition of egg lecithin to
bile prolongs the nucleation time, shifts cholesterol from the vascular phase to the non-
vascular phase and reduces the cholesterol/ PLs ratio of the remaining vesicles. These
findings suggest a protective effect of PLs.
It was later shown that in vitro PS prolongs the nucleation time and diminishes
cholesterol crystallization2.
PS is however a very minor component of biliary PLs in man and in any case ingested
PLs are not excreted into bile3.
If PS indeed promotes GS formation, the mechanism would probably be a metabolic
one.
                                                                
1 Halpern et al, 1993
2 Ringel et al, 1998
3 Pakula et al, 1996
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5.2.4 Proteins
The consumption of proteins with regard to risk in GS disease was probably the biggest
surprise in our analyses. Never before was protein consumption, especially of animal
origin, found to be so strongly associated with the disease under observation. The only
explanation we can suggest is that protein consumption raises directly the presence of
proteins (pro-nucleating agent) in human bile. This however, was not tested in the
present study. The nucleation time of bile from GS patients has been shown to be
significantly shorter than that of subjects without GSs1. This is commonly interpreted as
evidence for the presence of pro-nucleating agents (mainly proteins) in human lithogenic
bile2. As discussed in Chapter 2.2.4 nucleation is the first step in the formation of GSs.
Further studies are required to confirm our findings.
The high ORs might be explainable by a generally high consumption of animal foods in
Israel, or the subject number was too small after all.
5.2.5 Dietary fiber
Dietary fiber was shown to be negatively associated with GS development in this study.
This has been observed in other studies3 4 5 6. The protective properties of complex
carbohydrates can also be seen in many other diseases characterized by Western dietary
intake. It has been suggested that a low dietary fiber intake increases the risk of GS
formation due to decreased colonic motility and the resultant increase in fecal secondary
bile acids7 8.
                                                                
1 Burnstein et al, 1983
2 Portincasa et al, 1997
3 Scragg et al, 1984
4 Jørgensen et al, 1989
5 Sichieri et al, 1991
6 Moerman et al, 1994
7 Heaton et al, 1993
8 Marcus et al, 1986
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5.2.6 Zinc
Zinc as in other Western diseases was shown to be protective. The mechanism is not
well understood.
5.2.7 Drinks (incl. alcohol)
Alcohol consumption was inversely associated with the risk of GSs. This is in line with
a number of previous studies which have also reported alcohol as being protective 1 2 3.
This might explain the lower prevalence in men as opposed to women, as women
generally consume less alcohol than men. Thornton and colleagues4 suggested that the
protective mechanism of alcohol might be due to the HDL cholesterol-raising effect of
alcohol and the associated reduction in bile cholesterol saturation. That means that the
protective effect of alcohol would be via the liver, by increasing the conversion of
cholesterol into BAs5, or by altering the enterohepatic circulation of bile acids such as
DCA6 which is normally raised in the bile of patients suffering from GSs.
Coffee consumption was not significantly different among cases and controls. A number
of studies assessed the association between coffee consumption and GSs though with
statistically non-significant results7 8 9 10 11 12 13.
                                                                
1 Scragg et al, 1984
2 Maclure et al, 1990
3 Leitzmann et al, 1999
4 Thornton et al, 1983
5 Nestel et al, 1976
6 Yoshida et al, 1975
7 Sahl et al, 1998
8 Kratzer et al, 1997
9 Basso et al, 1992
10 Kono et al, 1991
11 La Vecchia et al, 1991
12 Pastides et al, 1990
13 Jørgensen T, 1989
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In only two studies the inverse association with coffee consumption was found to be
statistically significant 1 2. In contrast decaffeinated coffee was not associated with a
decreased risk of symptomatic GSs15.
There are a number of physiological mechanisms that support the protective effect of
coffee consumption from GSs. Coffee was found to increase cholecystokinin release3,
enhance GB contractility4, and may increase colonic motility5. These factors were
previously related to the development of GSs.
We found that soft drinks decreased the risk of GS formation. This may be due to the
resultant increased water consumption, which was found to be a protective factor in
other diseases6 7. On the other hand some soft drinks are rich in simple/ refined sugars.
There have been consistent reports on the positive association between the intake of
refined sugars and GS formation, usually in the same studies when there was also a
negative association with dietary fiber intake8 9 10. This observation points to the
direction that it is difficult to differentiate which of those two factors have an
independent effect. Furthermore, it has been speculated that high intake of refined sugars
increase the risk of GS formation as a result the following: the insulin rises and the result
is an increased cholesterol synthesis in the liver, part of which is probably released to the
GB and leads to a supersaturation of cholesterol in the GB4 5 6 11 12.
                                                                
1 Misciagna et al, 1996
2 Leitzmann et al, 1999
3 Douglas et al, 1990
4 Keiner F, 1965
5 Rao et al, 1998
6 Shannon et al, 1996
7 Lubin et al, 1997
8 Daly et al, 1997
9 Bennion et al, 1997
10 Scragg et al, 1984
11 DeLeon et al, 1978
12 Thornton et al, 1983
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5.2.8 Specific foods
Fish was surprisingly associated with an increased risk. It remained a risk factor even
after adjustment for fat and protein. Therefore, maybe another component is responsible
for the risk elevation. In Italy the opposite effect was observed1. A study done by Berr et
al2 found that supplementation of a Western diet with fish oil rich in n-3 PUFAs
changed the fatty acid composition of biliary PLs which was associated with a lower
cholesterol/PL molar ratio and lower cholesterol saturation of bile, most likely caused by
lecithin species-dependent coupling of cholesterol for secretion. On the other hand the
supplementation did not protect GS patients from nucleation of cholesterol crystals in
supersaturated GB bile; nor did it improve emptying of the GB. The authors’ conclusion
was that their results were not sufficient to recommend its use for medical treatment or
prophylaxis of GS.
One problem with interpreting our result for fish is that we did not differentiate between
the different types of fish. That means that fatty fish and less fatty fish were all analyzed
as one item which made a more correct interpretation impossible.
Chicken was also found to increase the risk of GS development. It is also important to
mention that chicken consumption is relatively high in Israel, due to the fact that beef is
expensive and pork is hardly eaten due to religious reasons. Again this could be
associated with its fat and protein content. Though after adjustment for fat and protein,
chicken remained an independent risk factor, which points to the direction that probably
another component is responsible.
                                                                
1 Misciagna et al, 1996
2 Berr et al, 1992
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Olives were found to increase the risk in Israel-born subjects. Though we could not
observe the same with olive oil, the team in Israel developed an hypothesis that might
explain that risk elevation. Olive oil is known to lower cholesterol in the blood. There is
a possibility that the serum cholesterol reduction leads to a cholesterol supersaturation of
the bile and thereby to cholesterol crystallization. In Israel, it was found that young
Druse Arabs have a high prevalence of GSs and they are known to drink olive oil every
morning (Dr. M. Rubin, verbal communication). This is not supported by the results of
this present study, where increased serum cholesterol was found to be a risk factor for
GSs.
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5.3 Non Diet-Related Factors
5.3.1 Medication-and supplement intake
Medication and supplement intake did not show any conclusive results mainly due to the
fact that only a very small number was using them. 35 cases and 31 controls used
chronic medication, and 33 cases and 39 controls used supplements. It was interesting
that only the controls (n=7) used laxatives, whereas elsewhere the opposite was
observed1. The opposite observation would be attributable to colonic motility as
mentioned in chapter 2.
5.3.2 Family history
Family history of GS disease was strongly associated with the risk of GS development.
This has been observed in many other studies in the past2 3 4. The authors concluded that
the familial effect could be due to hereditary and environmental factors. We also found
that 86% of the first-degree family members who were reported to have GSs were
women. On the maternal side of the subjects we found 21 GS carriers compared to 7 on
the paternal side. The large differences in reported GS carrying family members between
cases and controls could be slightly biased, as GS patients might be more eager to
inform themselves of other family members with GSs after diagnosis of GSs. We tried
to minimize this by interviewing the subjects closely to their US examination.
                                                                
1 Misciagna et al, 1996
2 Sarin et al, 1995
3 Gilat et al, 1983
4 Wheeler et al, 1970
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A study based in India1 also found that 65% of the positive relatives were women. In
vegetarians the reporting of a family history was more predominant with the female
cases2. Though this phenomenon is known, the gene responsible remains unknown to
this day. Therefore environmental influences might also be responsible, especially as it
is rather difficult to differentiate regarding family history whether it is due to genetics or
due to similar lifestyle, incl. dietary habits.
5.3.3 Physical activity
Physical activity was not associated with GSs in this study. This confirms a number of
previous studies which also could not find an association3 4 5. However, other studies
found a negative association6 7 8. Several mechanisms were suggested to contribute to
this association, including a direct effect of colonic motility9, and the effect of reduction
in insulin and insulin resistance10.
5.3.4 Smoking
Though in this study no differences in smoking habits were found between cases and
controls, another study performed on 96 cases and 118 age and gender matched
controls11 actually found smoking as well as jobs demanding hard labor to be protective.
This could be explained by the increase of colonic motility after smoking.
                                                                
1 Sarin et al, 1995
2 Pixley et al, 1985
3 Sarles et al, 1969
4 Sarles et al, 1978
5 Jørgensen et al, 1989
6 Misciagna et al, 1999
7 Williams et al, 1980
8 Kato et al, 1992
9 Liu et al, 1993
10 Eriksson et al, 1997
11 Linos et al, 1989
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On the other hand, in Australia1 it was observed that current-smokers versus never-
smokers had an increased risk of 1.3 in females and 1.6 in males. In Italy2 smoking was
found to be associated with risk of GSs. The results of various studies are thus
contradicting.
5.3.5 Hormonal influences (females only)
With regard to the hormonal role, this study could not show any significant differences
in female cases and controls in any of the parameters examined (age at menarche, use of
contraceptive pills and/or had HRT, number of pregnancies and/or children) mainly
because only a small number females used contraceptive pills and/or had HRT.
The same (non- )observation was made in Benha City3, where neither age at menarche,
duration of menstrual life, age at first pregnancy, multiparity nor duration of
contraceptive pill use showed any differences between the female cases and controls
studied. Neither could a study in vegetarian women4. In accordance with our study,
others did also not find an association with HRT (estrogen)  5 6 7.
Nevertheless, most cohort and CCSs have shown a positive association between
pregnancies and GSs3 4 8 9 10 11, fewer studies have not5 12.
                                                                
1 McMichael et al, 1992
2 Misciagna et al, 1996
3 Abdel-Rahman et al, 1993
4 Pixley et al, 1985
5 Jørgensen T, 1988
6 Scragg et al, 1984
7 Diehl et al, 1980
8 Misciagna et al, 1996
9 Bernstein et al, 1973
10 Wheeler et al, 1970
11 Friedman et al, 1966
12 Layde et al, 1982
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In pregnant women as compared to non-pregnant females the lithogenic index of the bile
was higher1, GB volume was larger, and emptying of the GB was frequently impaired2 3
4. Impaired GB emptying is well documented in cholelithiasis. It has been shown to exist
in patients with GSs, persisting after stone dissolution5. Jørgensen6 described significant
associations with young age at menarche and abortions. Young age at menarche
increases the fertility period. It was found that during the fertility period the lithogenic
index in bile increases7 8. A confounding factor could be the observation of the positive
association between obesity and early menarche 9.
In Australia10 it was observed that contraceptive use increased the risk of GS
development in young women, whereas it decreased it in the older females. However
many other studies did not find this association11 12. The lithogenic index in bile was
shown to increase during intake of oral contraceptives13 14 15. This was observed with
progestin, rather than with estrogen in normal doses16.
                                                                
1 Royal College of General Practitioners, 1982
2 Everson et al, 1992
3 Ylostalo et al, 1982
4 Braverman et al, 1980
5 Festi et al, 1990
6 Jørgensen T, 1988
7 von Bergmann et al, 1986
8 Bennion et al, 1977
9 Garn et al, 1986
10 Scragg et al, 1984
11 Abdel-Rahman et al, 1993
12 Pixley et al, 1983
13 Kern et al, 1982
14 Bennion et al, 1980
15 Bennion et al, 1976
16 Down et al, 1983
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5.3.6 Serum lipids
Regarding the analysis of all subjects we found that higher levels of total serum
cholesterol as well as serum TGs significantly elevated the risk of GS formation. The
literature is inconclusive regarding the associations with serum lipids. Nevertheless,
there are more studies that confirm elevated triglyceride levels in GS patients1 2, than
hypercholesteremia in GS carriers3. In Adelaide, total serum cholesterol was found to
have an inverse relation with GS development5.
A Japanese study4 could not confirm any relation, neither positive nor negative, between
serum TGs and total serum cholesterol and GS disease. Hypertriglyceridemia can be
induced by oral contraceptives5 and was shown in subjects sensitive to sucrose6, and
therefore in the past has been said to only be an additional marker for GS disease in
those patients who were exposed to other factors, such as certain diets and use of oral
contraception7. In this study neither a positive relation with oral contraceptives nor with
sucrose intake was observed. Therefore it seems to be an independent factor.
The fact that the Israel-born subjects had a higher levels of serum lipid is not entirely
clear. At least with serum cholesterol one would expect a lower level in people who
consume a Mediterranean diet, which is rich in olive oil. Olive oil has been shown to
lower cholesterol in the blood.
                                                                
1 Barbara et al, 1987
2 Tandon et al, 1996
3 Cavallini et al, 1987
4 Kono et al, 1988
5 Wynn et al, 1979
6 Reiser et al, 1979
7 Scragg et al, 1984
115
5.3.7 Family status
Marriage turned out to be a risk factor. As this cannot be a risk factor in itself we sub-
analyzed pure married pairs, ie. only those pairs where case and control were married.
The risk factors that were found for all subjects were also observed in the married pairs,
which confirms that other factors and not being married in itself are responsible for an
elevated risk of developing GSs. A study done in Melbourne also found that more cases
were married than controls1. There the authors concluded that a change in marital status
could have an influence on dietary intake, therefore on the subcutaneous fat.
                                                                
1 Wheeler et al, 1970
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6. CONCLUSIONS
The overall results of the study suggest that nutritional factors are strongly associated
with GS disease, as risk factors as well as protective factors. The strong association with
fat and protein of animal origin, suggests that foods of this origin increase the risk of GS
development.
Dietary fiber, zinc and liquids were found to be protective. This suggests that a fruit and
vegetable rich diet could be helpful.
In the future research should differentiate between younger and older subjects, as the
time-related exposure to potential risk factors might play an important role.
Our study did not relate to the mechanisms of these dietary influences. As many food
components are not secreted into bile it is likely that the effects are metabolic or affect
minor components in bile. For instance, pro-and anti-nucleating proteins modulate
cholesterol crystallization at minute concentrations. If and when dietary studies arrive at
agreed results, the mechanisms of the eventually identified dietary components can be
studied.
Although at present no food recommendations can be made to reduce the risk of GS
development, this study as well as previous studies suggest that a diet rich in complex
carbohydrates, low in fat and proteins, especially of animal origin might be beneficial.
The same recommendations can be found for a number of other diseases common in
Western countries1 2.
                                                                
1 Diehl et al, 1987
2 Kune G, 1996
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7. SUMMARY
The prevalence of cholesterol GSs has substantially increased in the last century,
especially in affluent countries. Genetic and environmental factors have been implicated
in the pathogenesis of GSs. Yet, the role of many specific environmental factors remains
unclear.
Aim
To study the role of diet and lifestyle habits in the etiology of asymptomatic GS disease.
Methods
Subjects with asymptomatic, GB stones detected by abdominal US, after a fast of = 8
hours, were enrolled. A total of 103 newly diagnosed GS patients (75 females, 28 males)
were matched by age, gender and ethnic origin to 103 GS -free subjects. All subjects
underwent abdominal US and were extensively interviewed on their dietary habits using
a FFQ, and on their lifestyle habits. Major food items were analyzed for their PL content
and included in the food composition tables.
Results
The paired analysis revealed the following dietary risk factors for the development of
GS:
High BMI (p<0.001), total fat intake (p=0.038), especially fat of animal origin
(p=0.001), total protein (p<0.001), protein of animal origin (p<0.001), PS (p=0.016),
chicken (p<0.001), high BMI at age 18 in females (p=0.007), in younger subjects (p=
0.029) and in Israel-born (p=0.006), high energy intake in females (p=0.023), beef in
young subjects (p=0.029), fish in older subjects (p=0.002), and olives in Israel-born
(p=0.031).
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The following factors were found to be negatively associated:
Dietary fiber (p=0.009), alcohol (p=0.039), starch in older subjects (p=0.030), zinc in
Israel-born (p=0.028), dried fruit in young subjects (p=0.022), and soft drinks in Israel-
born subjects (p=0.016).
In addition, being married (p=0.002), family history of GS (p<0.001), high serum
cholesterol (p< 0.05) and high serum TGs (p< 0.05) were found to correlate with the
presence of GSs.
Conclusions
As indicated earlier there are a number of previous studies that dealt with the etiology of
GSs, though the results are conflicting. One factor that might have led to the variability
of study results is the problem of study design as discussed in chapter 1. This study,
however, had many strengths due to its carefully planned study design, e.g.
determination of GB status in all studied subjects by US examination, inclusion of
recently diagnosed asymptomatic patients only, interview not longer than three months
after first diagnosis and the use of a comprehensive, validated FFQ. Nevertheless, there
is always a chance of recall bias and observer bias in those kind of studies and this has to
be accounted for.
Concluding, the results of the study suggest that nutritional factors are strongly
associated with GS disease, as risk factors as well as protective factors. The strong
association with fat and protein of animal origin, suggests that foods of this origin
increase the risk of GS development. The risk and protective factors which have been
identified in this study are very similar to those found in a group of diseases which have
been characterized as typical Western diseases1 2.
                                                                
1 Diehl et al, 1987
2 Kune G, 1996
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8. ZUSAMMENFASSUNG
Das Vorkommen von Cholesterin Gallensteinen (GS) hat sich im letzten Jahrhundert
deutlich erhöht, insbesondere in den entwickelten Industriestaaten. Eine Vielzahl von
genetischen und umweltspezifischen Faktoren wurden in der Vergangenheit im Hinblick
auf die Pathogenese als Entstehungsfaktoren von GS genannt. Dennoch blieb die Rolle
vieler spezifischer Umweltfaktoren bis dato ungeklärt.
Ziel:
Zielsetzung und Aufgabe der Studie ist die Untersuchung des Einflusses von Ernährung
und Lebensstil auf die Etiologie und Entstehung der asymptomatischen GS-Erkrankung.
Methodik:
Patienten, bei denen nach einer 8-stündigen Nahrungsmittelkarenz asymptomatische
Gallensteine durch eine abdominale US entdeckt wurden, wurden in die Studie
aufgenommen. Insgesamt wurden 103 neu-diagnostizierte GS Patienten (75 Frauen, 28
Männer) basierend auf Alter, Geschlecht und Ethnischem Ursprung 103 GS-freien
Subjekten zugeteilt. Alle Studienteilnehmer wurden einer abdominalen US
Untersuchung unterzogen und mit Hilfe eines FFQ in extensiven Interviews zu ihrer
Ernährungsweise und ihrem Lebensstil befragt. Die wichtigsten Nahrungsmittel wurden
nach ihrem Phospholipid (PL) Inhalt untersucht und in die Nahrungsmittel-
Zusammensetzungstabellen integriert.
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Ergebnisse:
Die Paarweise Analyse enthüllte die folgende positive Beziehung zwischen
Ernährungsfaktoren und der Entwicklung von GS:
Hoher BMI (p<0.001), gesamt Fetteinnahme (p=0.038), insbesondere Fett tierischen
Ursprungs (p=0.001), gesamt Protein (p<0.001), Protein tierischen Ursprungs (p<0.001)
und PS (p=0.016), Huhn (p<0.001), Gesamtenergie bei Frauen (p=0.023), Fisch bei
älteren Untersuchungsteilnehmern (p=0.002), Rindfleisch bei jüngeren
Untersuchungsteilnehmern (p=0.023), Oliven bei in Israel- geborenen
Untersuchungsteilnehmern (p=0.031).
Bei folgenden Faktoren wurde eine negative Assoziation gefunden:
Ballaststoffe (p=0.009) und Alkohol (p=0.039), Zink bei in Israel geborenen
Untersuchungsteilnehmern (p=0.028), Stärke bei älteren Untersuchungsteilnehmern (p=
0.030) und Trockenobst bei jüngeren Untersuchungsteilnehmern (p=0.022).
Desweiteren wurden folgende, von der Ernährungsweise unabhängigen Faktoren, als
positiv mit dem Entstehen von GS assoziert: Familiensstatus (p=0.002), familiäre
Krankheitsgeschichte von GS (p<0.001), erhöhter Gesamt-Blut-Cholsterinspiegel
(p<0.05) und erhöhter Triglycerinspiegel (p<0.05).
Abschließende Bemerkungen:
Wie schon zu Beginn angesprochen, gibt es einige ältere Studien die sich mit der
Entstehung von GS befasst haben.
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Die Ergebnisse dieser Studien sind jedoch größtenteils unstimmig und teilweise konträr.
Diese unstimmigen und unterschiedlichen Ergebnissen  könnten durch den jeweiligen
Untersuchungsaufbau verursacht worden sein. In dieser Untersuchung wurde daher
versucht die Probleme der vergangenen Studien soweit wie möglich und gezielt zu
vermeiden.
Insbesondere wurde durch einen sorgfältigen Studienaufbau auf folgende Dinge
geachtet:
1.) Ultraschall Untersuchung aller Studienteilnehmern
2.) Einbeziehung nur der asymptomatischen Patienten
3.) Ein Interviewer für die gesamte Studie
4.) Durchführung der Interviews innerhalb von 3 Monaten nach Stellung der
Erstdiagnose
5.) Nutzung eines verständlichen und akzeptierten Fragebogens (FFQ).
Der Verfasser weist darauf hin, daß die Existenz von ‘recall’ bias und Beobachter-Bias
in solchen Untersuchungen nie ganz ausgeschlossen werden kann. Dieses Risiko muß
und wurde daher auch in den statistischen Analysen einkalkuliert.
Die Ergebnisse der Untersuchung zeigen, daß Ernährungsfaktoren einen starken Einfluß
auf das Entstehen von GS haben, sowohl als Risikofaktoren als auch als
Präventionsfaktoren. Die starke Korrelation mit Fett und Protein tierischen Ursprungs
deutet darauf hin, daß möglicherweise Lebensmittel diesen Ursprungs das Risiko der GS
Entstehung erhöhen. Die in dieser Studie gefundenen Risiko- und Präventationsfaktoren
ähneln einer Gruppe von Krankheiten die als ‘typisch westliche Industrie-Krankheiten’
charakterisiert wurden1 2.
                                                                
1 Diehl et al, 1987
2 Kune G, 1996
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10. APPENDIX
10.1 FOOD FREQUENCY QUESTIONNAIRE
Exclusion criteria: I would like to know whether you have ever suffered or suffer from the
following diseases:
DISEASE no = 0
yes = 1
Since when
(years)
Drugs /
Medication
Operations
-Diabetes   _______ ________
-Inflammatory bowel disease   _______ ________
-Renal failure   _______ ________
-Heart failure   _______ ________
-Malignant tumour   _______ ________
Blood tests:
-Cholesterol _______mg%
-Triglycerides _______mg%
Other medical disorders: no = 0
yes = 1
Since when
(years)
Drugs /
Medication
Operations
-Thyroid disease   _______ ________
-Hypertension   _______ ________
-Constipation (<1 in 72 hrs)   _______ ________
-Diarrhoea (>3 within 1 day)   _______ ________
What is the reason for having this ultrasound examination? ______________________
___________________________________________________________________
Have you had an ultrasound examination done before? __________________________
If yes, what for? ______________________________________________________
When did the last one take place? _________________________________________
Have gallstones been found before, and when? ________________________________
Results of the present examination (Copy of the results? No=0; Yes=1):
-Gallstones: _________________________________________________________
-Number of gallstones: _________________________________________________
-Size of the big stone: __________________________________________________
-Units of H.U. in C.T.: _________________________________________________
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INTERVIEW DETAILS:
Date of interview:  Time of interview: 
Serialnumber: 
Place of interview: Home 1
Other (specify):________ 
My name is Eylath Kranz. I would like to ask you a few questions about your life-style. In
specific: food intake, physical exercise, illness and disease in the previous year.
_________________________________________________________________________
__
A. I WILL START WITH GENERAL QUESTIONS.
1. First name and family name:_________________________________________________
2. Name of
father:____________________________________________________________
3. ID:  4. Year of birth:      19
5. Country of birth:______________ 6. Year of immigration:19
7. Father’s country of birth:_________________ 
8. Mother’s country of birth:________________ 
9. Current
address:_____________________________________________________________
Street Place Tel. No.
B. FAMILY STATUS: married 1
single 2
divorced 3
widowed 4
C. DO YOU CONSIDER YOURSELF AS BEING: Secular 1
Traditional 2
Religious 3
Orthodox 4
Area Codes (Place of birth):
Western Europe, North America, South Africa, Australia, New Zealand: 01
Eastern Europe: 02
North Africa, Asia: 03
Israel: 04
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D: EATING HABITS
Adults may change their dietary habits because of health consciousness, chronic disease, etc. Did
you change your nutritional habits in the past, and / or due to your present symptoms?
no 0
yes 1
Change Reason Since when? Comments
Have you changed your eating habits due to teeth or chewing problems? (N=0; Y=1)
Are you eating (swallowing):1. fast; 2. normal; 3. slow
Change in eating patterns?
Interviewer: For each item ask as follows:
 ¨  Do you eat every day, several times a week, several times a month, never?
 ¨  How many (slices, portions, units) do you eat a day?
 ¨  What size (use pictures)?
 ¨  Have you changed your eating habits of (name item) for any reason during the past 15 years?
 
 if yes:
 
 ¨  How many years ago? (if less than one year change is omitted)
 ¨  How many times a week, how many times a month, did you eat__________ before this change
occurred?
 ¨  How many slices, portion, units?
 ¨  What size (use pictures)
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I would like to know more about your eating habits. For every food item I would like to know whether you
consume it every day, several times a week / month, or never. How many portions / units and portion sizes.
Lets start with how you eat each item now. If you changed your eating habits during the last 15 years, please
tell me how did you eat then.
Frequency: 7= every day; 1-6= depending on no. of times per week; A= once a month; B= twice a month;
C= three times a month; 8= altogether size a week; 9= altogether size a month.
CODE FOOD ITEM LATELY PREVIOUSLY
Bread (P.1) Frequency No. of
portions
Portion
size
Time
changes
    Comment Frequency No. of
portions
Portion
size
0104 Wholemealbread  ,   ________  , 
0101 White bread, Chala  ,   ________  , 
0103 Rolls (small)  , 1  ________  , 1
0105 Pita  , 1  ________  , 1
0106 Crackers, matzos  , 1  ________  , 1
01__ Other_____________  , 1  ________  , 1
Spreads & fats (P.2)
0202 Butter (spread)  ,   ________  , 
0201 Margarine (spread)  ,   ________  , 
0211 Butter (cooking)  , 1  ________  , 1
0210 Margarine (cooking)  , 1  ________  , 1
0216 Olive oil (teaspoon)  , 1  ________  , 1
0205 Salad oil:________  , 1  ________  , 1
0206 Oil (frying)  , 1  ________  , 1
0204 Salad mayonnaise
(teaspoon)  ,
1  ________  , 1
Eggs
0301 Eggs (cooked)  , 1  ________  , 1
0306 Eggs (fried)  , 1  ________  , 1
0302 Egg white (only)  , 1  ________  , 1
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CODE FOOD ITEM LATELY PREVIOUSLY
Cakes, cookies &
sweets(P.3 & 4)
Frequency No. of
portions
Portion
size
Time
changes
    Comment Frequency No. of
portions
Portion
size
0715 Cake(sand, chocolate)  ,   ________  , 
0718 Cheese cake  ,   ________  , 
071__ Cake:____________  ,   ________  , 
0721 Biscuits, cookies (dry)  , 1  ________  , 1
0731 Crackers (salty)  , 1  ________  , 1
0711 Honey, jam (teaspoon)  , 1  ________  , 1
0704 ice cream (dairy)^  ,   ________  , 
0732 ice cream (parve)^  ,   ________  , 
0713 Halva (P.6)  ,   ________  , 
0733 Milk chocolate*  ,   ________  , 
0708 Bitter chocolate*  ,   ________  , 
1008 Diet-chocolate*  ,   ________  , 
0413 Whipped cream
(spoon #)  ,
1  ________  , 1
07__ Other sweets_______  , 1  ________  , 1
[* 1=piece; 2=bar]
[^ 1=scoop; Artic=2 scoops;
3=P.5]
[# on cake=2 teaspoons]
Hot Drinks (Mugs)
050__ Coffee:__________  , 1  ________  , 1
0701 Cocoa  , 1  ________  , 1
0503 Tea  , 1  ________  , 1
0702 Sugar
(teaspoon(s)/day)  ,
1  ________  , 1
1002 Artificial sweetener  , 1  ________  , 1
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Milk products
(1= portion
[250g]=18
teaspoons;
2=teaspoons)
Frequency No. of
portions
Portion
size
Time
changes
    Comment Frequency No. of
portions
Portion
size
04__ Milk (glasses) ___%  , 1  ________  , 1
0401 Cheese (yellow) (P.6)  ,   ________  , 
0403 Cheese (white, 9 %)  ,   ________  , 
0404 Cheese (white, 5 %)  ,   ________  , 
0426 Low-fat white cheese  ,   ________  , 
0406 Salty + melted Cheese
(P.6)  ,   ________  , 
0407 'Leben', Yoghurt  ,   ________  , 
0410 Yoghurt (fruit, sweet)  ,   ________  , 
0412 Sour cream  ,   ________  , 
04___ Other_____________  ,   ________  , 
Poultry, Meat
1203 Schnitzel (poultry),
(P.7)  ,   ________  , 
1201 Chicken, ¼  , 1  ________  , 1
1202 Chicken (grilled), ¼  , 1  ________  , 1
1206 Meatballs (chicken);
(P.8,9)  ,   ________  , 
1205 Turkey (red), (P.10)  ,   ________  , 
1901 Meat (cattle), (P.10)  ,   ________  , 
1903 Meatballs (beef),
(P.8,9)  ,   ________  , 
2001 Lamb (shishlik) (P.10)  ,   ________  , 
2303 Liver (P.10)  ,   ________  , 
____ Other:________  ,   ________  , 
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CODE FOOD ITEM LATELY PREVIOUSLY
Cooking style-
meats
Frequency No. of
portions
Portion
size
Time
changes
    Comment Frequency No. of
portions
Portion
size
2219 Poultry & beef, fried  , 1  ________  , 1
2230 Poultry & beef,cooked  , 1  ________  , 1
2240 Poultry & beef, grilled  , 1  ________  , 1
Sausages
2201 Salami (slices)  , 1  ________  , 1
2203 Turkey breast (slices)  , 1  ________  , 1
2202 Hot sausages, (whole)  , 1  ________  , 1
Fish
1302 Gefillte fish  , 1  ________  , 1
1301 Zoo carp  , 1  ________  , 1
1311 Deep sea fish (Bakla)  , 1  ________  , 1
1304 Sardines (slices)  , 1  ________  , 1
1305 Tuna, mackerel (tin*)  , 1  ________  , 1
1306 Smoked fish (slices)  , 1  ________  , 1
1307 Herring (slices)  , 1  ________  , 1
13__ Other_____________  , 1  ________  , 1
[* tin=170g]
Cooking style-fish
1319 Fish fried  , 1  ________  , 1
1330 Fish cooked  , 1  ________  , 1
1340 Fish grilled  , 1  ________  , 1
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Cereals
(1=spoon; 2=P.11)
Frequency No. of
portions
Portion
size
Time
changes
    Comment Frequency No. of
portions
Portion
size
0109 White rice  , 2  ________  , 2
0124 Brown rice  , 2  ________  , 2
0112 'Burgol' (spoon)  , 1  ________  , 1
0113 Oats [Quaker] (spoon)  , 1  ________  , 1
0114 Semolina (spoon)  , 1  ________  , 1
0110 Semolina pearls (soup)  , 1  ________  , 1
0115 Spaghetti, macaroni
(P.12)  ,
2  ________  , 2
0111 'Kossemet' (spoon)  , 1  ________  , 1
0116 Noodles (soup)  , 1  ________  , 1
0117 'Shkedej Marak'  , 1  ________  , 1
2401 Bran [Subin] (spoon)  , 1  ________  , 1
0121 Corn Flakes (spoon)  , 1  ________  , 1
2402 'Granola' (spoon)  , 1  ________  , 1
Ethnic dishes
0603 Pizza (regular size)  , 1  ________  , 1
0604 'Tschulend' (chamin)
(P.11)  ,
2  ________  , 2
0607 'Lewiwot, Knisches,
(& potato dishes)  ,
1  ________  , 1
0608 'Kube' (piece)  , 1  ________  , 1
0610 'Falafel' (½ port., 3
balls)  ,
1  ________  , 1
0611 'Humus salad' (spoon)  , 1  ________  , 1
0612 'Tehina salad' (spoon)  , 1  ________  , 1
0613 'Chilbe' (teaspoon)  , 1  ________  , 1
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CODE FOOD ITEM LATELY PREVIOUSLY
Frequency No. of
portions
Portion
size
Time
changes
    Comment Frequency No. of
portions
Portion
size
0420 Cheese dishes:
‘Pashtedot’,Blintzes  ,
1  ________  , 1
0620 'Malauach, Jachnun'  , 1  ________  , 1
'Pitzuchim' (2=100g;
1=single)
1401 'Garinim' [Sunflower]  ,   ________  , 
1403 Almonds  ,   ________  , 
1404 'Egosim' [Nuts]  ,   ________  , 
1402 'Botnim' [Peanuts]  ,   ________  , 
1405 'Fistuk Chalavi'  ,   ________  , 
Legumes
1110 'Tivol' (1=Shnitzel;
2=sausage)  ,   ________  , 
1101 Dried 'Shuit'
(1=spoon; 2=P.11)  ,   ________  , 
1103 Dried lentils (spoon)  , 1  ________  , 1
1104 Dried peas (spoon)*  , 1  ________  , 1
1102 Dried 'Humus' (spoon)  , 1  ________  , 1
[*In soup = 2 spoons]
Vegetables (P.13)
1701 Olives (single)  , 1  ________  , 1
0935 Pickles (single)  , 1  ________  , 1
0937 'Resek Agwaniot'  , 1  ________  , 1
0901 Avocado, ¼  , 1  ________  , 1
0902 Tomatoes  , 1  ________  , 1
0903 Cucumber  , 1  ________  , 1
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Frequency No. of
portions
Portion
size
Time
changes
    Comment Frequency No. of
portions
Portion
size
0904 Radish  , 1  ________  , 1
0932 Onion  , 1  ________  , 1
0905 Green Onion  , 1  ________  , 1
0906 Lettuce (P.13)  , 2  ________  , 2
0907 Green pepper, paprika  , 1  ________  , 1
0909 Carrots (1=one;
2=P.13; 3=P.5)  ,   ________  , 
0940 Broccoli  , 2  ________  , 2
0916 Cauliflower  , 2  ________  , 2
0912 Cabbage (red/white)  , 2  ________  , 2
0913 'Shuit' (green/yellow)  , 2  ________  , 2
0915 'Bamia' [Okra]  , 2  ________  , 2
0929 Fresh Peas  , 2  ________  , 2
0924 Corn, maize (1=one;
2=P.13)  ,   ________  , 
0918 Eggplant salad
(1=spoon); 2=P.14)  ,   ________  , 
0917 Eggplants (fried)  , 1  ________  , 1
0919 Spinach  , 2  ________  , 2
0921 'Lefet' [Turnip](single)  , 1  ________  , 1
0922 Celery (spoon)  , 1  ________  , 1
0923 Artichoke (single)  , 1  ________  , 1
0910 Zucchini (1=single;
2=P.13)  ,   ________  , 
0927 'Selek' [Beet root]
(1=one; 2=P.13)  ,   ________  , 
0931 Chips (P.11)  , 2  ________  , 2
0930 Potatoes (1=one;
2=P.13)  ,   ________  , 
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Frequency No. of
portions
Portion
size
Time
changes
    Comment Frequency No. of
portions
Portion
size
0938 Parsley, Dill (portion)  , 1  ________  , 1
0920 'Ful' [Broad bean]
(P.13)  ,
2  ________  , 2
0934 Garlic (tooth)  , 1  ________  , 1
0615 Ketchup (spoon)  , 1  ________  , 1
0___ Other:____________  , 1  ________  , 1
Cooking style
vegetables
0942 Vegetables fried with
onions  ,
1  ________  , 1
0941 Fried / cooked with
(little) oil  ,
1  ________  , 1
Fruits (1= single);
[seasonal]
0801 Oranges  , 1  ________  , 1
0802 Grapefruits (½)  , 1  ________  , 1
0803 Clementines  , 1  ________  , 1
0804 Lemons  , 1  ________  , 1
0805 Freshly pressed juice  , 1  ________  , 1
0807 Apples  , 1  ________  , 1
0809 Pairs  , 1  ________  , 1
0810 Bananas  , 1  ________  , 1
0813 Grapes (Cluster)  , 1  ________  , 1
0811 Strawberry*  ,   ________  , 
0812 'Afarsemon'
[Persimmon]  ,
1  ________  , 1
0814 Honey melon (½
small)  ,
1  ________  , 1
(*single=1; 100g=2; 3=P.5)
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Frequency No. of
portions
Portion
size
Time
changes
    Comment Frequency No. of
portions
Portion
size
0815 Watermelon (¼)  , 1  ________  , 1
0816 'Afarsek' [Peach]  , 1  ________  , 1
0817 Apricots  , 1  ________  , 1
0818 Plums  , 1  ________  , 1
0819 'Shessek' [Loquat]  , 1  ________  , 1
0820 Fresh figs  , 1  ________  , 1
0825 Mango  , 1  ________  , 1
1817 Dried apricots  , 1  ________  , 1
1818 Dried plums  , 1  ________  , 1
1820 Dried figs  , 1  ________  , 1
1802 Dried dates  , 1  ________  , 1
_____ Other:____________  ,   ________  , 
Drinks (glasses)
1505 Preserved Juice  , 1  ________  , 1
0500 Water / Soda  , 1  ________  , 1
1503 Lemonade  , 1  ________  , 1
1507 Coca Cola  , 1  ________  , 1
1601 Wine (100g)  , 1  ________  , 1
1603 Beer (glass)  , 1  ________  , 1
1605 Cognac/Whisky  , 1  ________  , 1
Other Foods or
Drinks worth noting
_____ _________________
_  ,   ________  , 
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E. SUPPLEMENTS
Have you, in the past year, taken the following supplements:
Supplement 1=Yes,
0=No
Since when?
(year)
If in the past
                   When?                              For how long?
                       (year)                                              (months)
Calcium    
Vitamin D,
Multivitamin    
Fish oil    
‘Tachshirei Subin’    
Have you got a food allergy?_____________________ Since when? 
F. DRUGS
Have you taken, or still take, drugs for a period of 3 months or longer? (15-20 years back)
Reason (Disease) Name/Kind of drugs Regularly?
0=No; 1=Yes
Period of intake
Months                    Years
__________________ __________  ___
__________________ __________  ___
__________________ __________  ___
__________________ __________  ___
__________________ __________  ___
G. FOR WOMEN ONLY
Age at first
pregnancy
Age at first
menarche
Age at menopause No. of “life”
births
No of pregnancies
    
Pill (1=Yes; 0=No) Oestrogen (1=Yes; 0=No) Others (1=Yes; 0=No)
  
Months of lactation: 
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H: PHYSICAL ACTIVITY
Please give details on the number of hours during a day/week/month you are spending on the
following activities:
Frequency: 7= every day; 1-6= depending on no. of times per week; A= once a month; B= twice a month;
C= three times a month; 8= altogether size a week; 9= altogether size a month.
Degree of activity Kind of activity Frequency No of hours
Resting Sleeping, lying 7 
At work  
While watching
TV, reading  
During meals 7 
Sitting
While driving  
At work  Light activity
At home (incl.
cooking)  
In the past few years Before the change
Frequency No of hours If there has been
a change in
activities, how
many years ago?
Frequency No of hours
At work:
____________     
Gardening     
Cleaning     
Moderate /
Heavy
Activity
Other:_______     
Distance
walking     
Jogging     
Gymnastics     
Swimming     
Dancing     
Voluntary
activity
Other:______     
How many times per day are you using stairs? 
How many floors? 
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I. EDUCATION
Years of education:                                                                          
Profession:                                                                                        
Husband’s profession:                                                                     
Please give details on the places where you have worked so far:
Name of workplace No of
years
Your job?
(Profession)
What is
produced?
Have you been in
contact with any
chemicals? Specify.
_______________  _______ _____ ________
_______________  _______ _____ ________
_______________  _______ _____ ________
_______________  _______ _____ ________
_______________  _______ _____ ________
01 = Lead (oferet) 02 = Pesticides 03= Organic solvents
04 = Rays 05 = Colour __ = Other:________
K. SMOKING
1.Are you smoking? No 0
Yes 1 (continue with 3)
2.Have you ever smoked? No 0 (continue with L)
Yes 1
3.How many cigarettes/day? 
4.Have you ever smoked more? No 0 (continue with 6)
Yes 1
5.How many did you smoke then? 
6.When did you start? 
7.When did you quit? 
8.How many years did you smoke? 
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L. WEIGHT
During the past years:  Most of your life: 
At age of 18*: 
{* If not known: 001=thinner; 002=fatter; 003=No change}
M. HEIGHT
 cm
N. FAMILY HISTORY
Please specify on diseases/illnesses that have occurred in your family, also on deceased family
members:
Member Dead=0
Alive=1
Disease codes and names
Mother   ___________________________
Father   ___________________________
Grandmother
(mother)   ___________________________
Grandfather
(mother)   ___________________________
Grandmother
(father)   ___________________________
Grandfather
(father)   ___________________________
Member How
many?
Disease codes and names
1.        2.      3.       4.       5.
Daughters       ________________
Sons       ________________
Sisters       ________________
Brothers       ________________
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Member How
many?
Disease codes and names
1.        2.      3.       4.       5.
Aunts
(mother)       ________________
Uncles
(mother)       ________________
Aunts
(father)       ________________
Uncles
(father)       ________________
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24 Hour Recall
Time What was consumed? Portion Position
